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Reproduction is influenced by the physiological and environmental modulation of the 
hypothalamic gonadotropin-releasing hormone (GnRH) neuronal network. GnRH 
hypothalamic activity is reflected in the systemic circulation by its downstream 
effector, luteinising hormone (LH). During stress, the GnRH-dependent LH activity 
that is required for adequate gonadal development and function is suppressed by 
glucocorticoids secreted by the adrenal glands. Emerging research in the field of 
stress-induced infertility show glucocorticoids do not directly inhibit GnRH activity 
and instead may act via the inhibitory RFamide-related peptide (RFRP) neurons, 
which suppress GnRH secretion. Thus far, this intermediary inhibitory role of RFRP 
neurons between the stress and reproductive axes is mainly supported by the 
upregulated expression of hypothalamic RFRP activity with stress in both sexes. 
Using a transgenic mouse model, the experiments in this thesis examine whether 
hypothalamic RFRP neuronal signalling is required for stress-induced infertility and 
whether increased RFRP activity is sufficient in mediating downstream suppression of 
LH in vivo. 
 
The chemogenetic approach of Cre-dependent DREADD (designer receptors 
exclusively activated by designer drugs) expression was used to selectively 
manipulate hypothalamic RFRP neuronal signalling via the administration of the 
DREADD agonist, clozapine-n-oxide (CNO). With the use of Fos-related antigens as 
the neuronal activity marker, immunohistochemical staining of hypothalamic brain 
sections confirmed significant suppression of RFRP activity in DREADD-silenced 
mice. Similarly, a significant upregulation of RFRP activity was confirmed in 
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DREADD-activated mice in comparison to control mice. Additional data also showed 
that this increase in RFRP activity also caused a marked release of glucocorticoids in 
both sexes. 
 
To assess the requirement of RFRP neurons in stress-induced infertility, glucocorticoid-
mediated inhibition of reproductive activity was achieved by long-term 
subcutaneously-placed corticosterone implants, with subsequent CNO-induced RFRP 
neuronal silencing. The suppression of LH pulse frequency and amplitude by 
glucocorticoids was observed for female control mice, but strikingly not for the RFRP-
silenced mice. However, no significant effect of RFRP silencing was seen on pulsatile 
LH secretion in males. Similarly, hyperactivation of the RFRP neuronal population 
was sufficient to suppress LH secretion in females, but not in males. Attempts were 
also made to develop an in vivo model where the effect of RFRP neuronal signalling 
could be measured on the pre-ovulatory LH surges in females. The naturally 
occurring LH surge in intact female mice and the artificially-induced LH surge in 
gonadectomised mice were assessed, but an adequate control for glucocorticoid 
treatment could not be configured. These results showed a need for further 
optimisation before the effect of RFRP neuronal manipulation could be measured on 
glucocorticoid-induced inhibition of the LH surge. 
 
Nonetheless, in this thesis I have demonstrated using Cre-dependent DREADD 
technology, a novel, sex specific physiological necessity of RFRP neurons for stress-
induced suppression of pulsatile reproductive hormone secretion. This testing of 
physiological properties of RFRP neurons may lead to clinical trials of RFRP 
antagonists, at least in females, to restore homeostasis in reproductive hormone 
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Infertility, currently defined as the inability to achieve a pregnancy after twelve 
months of regular unprotected intercourse, astonishingly affects one in four couples 
worldwide (Zegers-Hochschild et al., 2009; Mascarenhas et al., 2012; Inhorn and 
Patrizio, 2015). It is, however, often a relatively less prioritised disease of the 
reproductive system in the presence of other life-threatening conditions, especially in 
countries with scarce healthcare resources. Nonetheless, the psychosocial burden 
caused by infertility, coupled with the biological drive to procreate, remains a 
prevalent issue in all societies to date (Boivin et al., 2007; Chachamovich et al., 2010; 
Mascarenhas et al., 2012). In 1982, Machelle Seibel and Melvin Taymor reviewed the 
emotional aspects associated with infertility, and postulated psychological stress to be 
a ramification of the inability to conceive a child (Seibel and Taymor, 1982). Aligning 
with Seibal and Taymor’s hypothesis, an infertility diagnosis is essentially reported as 
a life crisis with patients experiencing a tremendous amount of emotional turmoil in 
conjunction with causing anxiety and depression, all accumulating to induce 
psychological stress (Rooney and Domar, 2018). In a literature review, 25-60% of 
infertile individuals were reported to have psychiatric symptoms (De Berardis et al., 
2014), while in another study 9.4% of the women have reported suicidal thoughts or 
attempts (Shani et al., 2016).  
 
The understanding of psychological stress in infertility, however, has now evolved 
from being a mere consequence to also being a causal factor in the disease of the 
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reproductive system.  In 2004, Chen et al.  reported that first-time visitors to their 
fertility clinic had a strikingly high 40.2% prevalence of a psychiatric disorder among 
the cohort. Where the use of assisted reproductive technology (ART) is advocated for 
fertility treatment, several studies show significantly lower ART live birth success 
rates in women with a prior diagnosis of chronic psychological stress (Klonoff-Cohen 
et al., 2001; Sejbaek et al., 2013; Xu et al., 2017). Such research into the efficacy of 
fertility treatment has ignited awareness of the precursory role that stress has in 
reproductive dysfunction. It is though, important to highlight that there is little 
research in the field that is inclusive of both men and women. The recorded high 
susceptibility to stress in females has led them to be the sole focus in the majority of 
clinically conducted research (Breslau et al., 1997; Sadeghian et al., 2006; Cousineau 
and Domar, 2007; Taghipour et al., 2017). Furthermore, psychological interventions 
that lower perceived stress have been associated with an increased pregnancy rate and 
have led to the prioritisation of attentive care to the mental well-being of the patient 
undergoing fertility treatment (Deka and Sarma, 2010; De Berardis et al., 2014; Rooney 
and Domar, 2018). Evidently, stress plays a central role in the causes and consequences 
of infertility and has therefore sparked interest among researchers to understand the 
biological interactions between the two.  
 
Both the reproductive and the stress axes share architectural similarity in their control 
systems. The stress response is controlled by the hypothalamic-pituitary adrenal 
(HPA) axis that secretes glucocorticoids into the systemic circulation. Glucocorticoids 
exert their effects through their ubiquitously distributed intracellular receptors to 
enhance immediate survival at the cost of metabolic and reproductive processes that 
are vital for procreation (Charmandari et al., 2005). Thus, the homeostasis of the 
reproductive system is disrupted, which is an energy demanding process that requires 
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precise regulation from hormones secreted by the hypothalamic-pituitary gonadal 
(HPG) axis (Plant and Zeleznik, 2014). Several studies that report the effect of stress 
on fertility show a lower conception rate in psychiatrically distressed individuals with 
deteriorated sperm quality, ovulatory capacity, and implantation, compared to the 
non-stressed fertile controls (Domar 2000; Zorn 2008; Gourounti 2011; Klonoff-Cohen 
2001). Every aspect of the reproductive process is thus compromised by stress, in both 
males and females. Individuals with pre-existing genetic conditions are reported to be 
at high risk of experiencing chronic stress which may exacerbate their predisposal to 
reproductive dysfunction (Rooney and Domar, 2018). Despite this widely known 
suppressive effect of stress on the development and function of the reproductive axis, 
the nature of neuronal interaction among the two systems remains enigmatic.  
 
Since the discovery of RFamide-related peptide (RFRP) neurons and their secreted 
peptide RFRP-3, 20 years ago (Hinuma et al., 2000; Tsutsui et al., 2000), their role in 
stress and reproduction has been heavily studied. The knowledge of RFRP-3 in 
mammals arose with its functional and structural homology to gonadotropin-
inhibitory hormone (GnIH) that modulates central inhibition of the reproductive axis 
in the avian brain (Kriegsfeld et al., 2006; Ubuka et al., 2009). Interest in mammalian 
RFRP-3 has primarily focused on how it negatively regulates the reproductive system. 
The literature to date exhibits simultaneous upregulation of Rfrp-3 mRNA in the RFRP 
neurons localised to the dorsomedial hypothalamus (DMH) in the mammalian brain 
with the extensive physiological stress response, especially in anxiety disorders (Kirby 
et al., 2009). It is thus possible RFRP neurons play a crucial intermediary role in 
glucocorticoid-induced suppression of the reproductive system. Furthering our 
current knowledge of the functional relationship between RFRP neurons, infertility 
and stress will better our understanding of the mechanisms underlining stress-
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induced infertility, and potentially may aid development in the therapeutic strategies 
ameliorating the efficacy of fertility treatments. 
 
The following chapter explores the intricate hormonal as well as neuronal interactions 
of the HPG and HPA axes and evaluates research on the neuroendocrine role of RFRP 




2 Literature Review 
 
2.1 Hypothalamic pituitary gonadal axis 
The regulation of the reproductive system is initiated at the level of the hypothalamus 
by neurosecretory cells that synthesise and secrete gonadotropin releasing hormone 
(GnRH) into the hypophyseal portal capillaries. GnRH is episodically introduced into 
the circulation to stimulate the pulsatile release of the gonadotropins luteinising 
hormone (LH) and follicle-stimulating hormones (FSH) from gonadotrope cells of the 
anterior pituitary gland (Plant and Zeleznik, 2014). These gonadotropins are crucial 
for gonadal function. In males, LH controls androgen synthesis by the Leydig cells 
present in the testis and thus mediates testosterone release. Whereas, FSH acts on 
Sertoli cells to maintain spermatogenesis (Heindel et al., 1975). Testosterone exerts a 
negative feedback on the reproductive axis so that homeostasis in the HPG axis is 
maintained (Plant and Zeleznik, 2014).  
 
A much more complicated picture is painted in females where gonadotropin-induced 
secretion of oestrogens by the ovarian follicles can have both negative and positive 
feedback on the HPG axis. Through negative feedback, the release of GnRH and thus 
the gonadotropin LH is maintained at low levels of episodic secretion into the 
circulation while FSH stimulates ovarian follicle growth (Richards and Pangas, 2010). 
As the ovaries mature, oestrogen levels gradually rise and eventually switch to 
positive feedback in order to induce a surge of GnRH, and consequently an LH surge 
that is vital for ovulation to occur (Christian and Moenter, 2010). The establishment of 
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these two alternating modes of GnRH secretion ‘pulsatile’ and ‘surge’ in the HPG axis, 
is the system which mammals have evolved for controlling the dual functions of 
maintaining early follicular growth and luteal function (requiring moderate levels of 
gonadotrophins), and driving ovulation (requiring very high levels of gonadotropins).  
 
 
Figure 2.1 Schematic overview of the hypothalamic pituitary gonadal (HPG) axis. The 
GnRH neurons from the hypothalamus stimulate secretion of the LH and FSH  from the 
anterior pituitary gland. These hormones travel to the gonads to drive steroid and gamete 
production. The sex steroids testosterone in males and oestradiol and progesterone in females 
feedback to the hypothalamus and pituitary to maintain homeostasis of the HPG axis (+ 
represents positive feedback, - represents negative feedback).  
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2.1.1 Hypothalamic regulation of the HPG axis 
The central drivers of the reproduction, GnRH neurons, are loosely scattered in the 
preoptic area (POA) and medial septum, and in some species including humans their 
location extends rostrally as far as the arcuate nucleus (ARC) of the hypothalamus 
with their neurosecretory domain in the median eminence (Herde et al., 2013). The 
distal ‘dendron’ of GnRH neuron in the vicinity of the median eminence seems to 
serve the role of both dendrites and axons (Herde et al., 2013). Interestingly, GnRH 
neuronal activity remains mainly suppressed until puberty, despite their 
development to an apparently full level of potential functionality while still within the 
fetus (Kumar et al., 2014; Herbison, 2016). Upon puberty onset, there is an increase in 
activity of the GnRH neurons which is fundamental to both pulsatile LH secretion that 
is vital for gonadal function and sexually dimorphic pre-ovulatory LH surge 
generation (Knobil, 1974; Herde et al., 2013). This remarkable temporal control is an 
ongoing focus of research into GnRH neuronal function.  
 
Current literature on the modulation of gonadotropin secretion pattern largely 
supports the mechanism of extrinsic inputs from other hypothalamic neurons to 
GnRH neurons rather than marking it as an intrinsic characteristic of the GnRH 
neurons. Two upstream factors in particular, kisspeptin and RFRP-3, are considered 
crucial for having an activating and inhibiting effect on the GnRH neurons, 
respectively. As discussed earlier, GnRH secretion is regulated by feedback from 
gonadal steroids. Testosterone induces negative feedback in males via androgen 
receptors (AR), and oestrogens signal their negative and positive feedback in females 
via their alpha oestrogen receptor (ERα) (Krey and Mcginnis, 1990; Glidewell-Kenney 
et al., 2007; Herbison, 2008). Surprisingly, GnRH neurons themselves do not express 
ERα and AR and therefore require external stimulation from kisspeptin neurons and 
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RFRP neurons, which express receptors to recognise afferent sex steroid input 
(Herbison, 1995; Kriegsfeld et al., 2006; Molnar et al., 2011). It should be noted, 
however, that expression of AR on RFRP neurons is markedly lower than ERα in both 
male and female mice (Molnar et al., 2011). It is well accepted that kisspeptin, acting 
on its G protein-coupled receptor KISS1R, is the most potent known stimulator of the 
GnRH neurons and is required for both GnRH pulse generation and the surge 
secretion (reviewed by: Skorupskaite et al., 2014; Javed et al., 2015; Shruti and Prevot, 
2016). In recent years, considerable advances have been made concerning the 
hypothalamic stimulatory control of the HPG axis by kisspeptin whilst comparatively 
less progress has been made on the inhibitory modulation of GnRH and LH.  
 
2.1.1.1 RFRP neurons: interaction with the HPG axis   
Collective results from the immunochemical analyses of human, mouse, rat, ewe and 
hamster brains suggest that RFRP cell bodies are mainly localised to the dorsomedial 
hypothalamus (DMH) (Ukena and Tsutsui, 2001; Kriegsfeld et al., 2006; Clarke et al., 
2008; Dardente et al., 2008; Gibson et al., 2008; Qi et al., 2009; Ubuka et al., 2009). In 
humans and in rodent species, RFRP axons project to GnRH neurons, median 
eminence and kisspeptin neurons (only tested in rodents) (Ubuka et al., 2009; Poling 
et al., 2013). In mammalian species, RFRP neurons secrete peptides RFRP-1 and RFRP-
3, however, only the latter has been confirmed to participate in inhibiting reproductive 
hormone secretion from the HPG axis to date (Pineda et al., 2010).  
 
The in vitro cell-attached recording of GnRH neurons in male and female brain 
sections show that RFRP-3 application (1 µM) induces rapid and repeatable inhibitory 
effect on the firing rate of at least 41% of GnRH neurons. Furthermore, this inhibitory 
effect was shown to be independent of gamma-aminobutyric acid (GABA), as it was 
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sustained in the presence of GABAA antagonist picrotoxin (Ducret et al., 2009). This is 
substantial evidence for the direct modulation of GnRH activity (or at least, not via 
the common neurotransmitter GABA) by RFRP neurons. Another similar in vitro cell-
attached recording by Wu et al. (2009) showed direct inhibitory effect of RFRP-3 is 
mediated via postsynaptic  barium (Ba2+) sensitive potassium (K+) current mechanism 
in the GnRH neurons that results in hyperpolarisation and could potentially stop 
stimulation from the kisspeptin-activated KISS1R. In agreement with this, RFRP-3 
receptors GPR147 are localised in GnRH neurons and also in kisspeptin neurons 
(Poling et al., 2013). Indeed, i.c.v. RFRP-3 administration significantly decreased 
kisspeptin and GnRH mRNA levels in the hypothalamus, and GnRH mRNA 
expression was restored with the concomitant administration of GPR147 antagonist 
in female rats  and mice (Xiang et al., 2015; Han et al., 2017).  Such findings are 
compelling evidence for the direct and indirect inhibition of GnRH secretion by RFRP 
neurons.  
 
Despite projections of RFRP neurons in the median eminence and expression of 
GPR147 in human gonadotrophs (Ubuka et al., 2009), studies in rodents and possums 
show little evidence for hypophysiotropic effects of RFRP neurons. Many studies have 
found little evidence for RFRP fibres in the median eminence external zone (the 
‘neurosecretory zone’, and analysing the uptake of neuronal tract tracing dyes from 
the periphery, RFRP neurons were not found to project outside the blood-brain barrier 
(Rizwan et al., 2009; Harbid et al., 2013). Additionally, an intravenous bolus of RFRP-
3 in rats did not suppress gonadotropin secretion from the pituitary (Rizwan et al., 
2009). Alternatively, supporting the hypophysiotropic effect of mammalian RFRP-3, 
an in vitro experiment on cultured ovine pituitary cells by  Clarke et al. (2008) observed 
that RFRP-3 in a dose dependent manner prevents increase in cytoplasmic calcium 
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levels that is essential for LH secretion from gonadotrophic cells. However, the 
inhibitory effect of RFRP-3 was only shown in the presence of GnRH stimulation and 
similar observations were made by Rizwan et al. (2009) which reported that peripheral 
administration of a GPR147 receptor antagonist was unable to rescue plasma LH 
concentration in rats treated with the GnRH receptor antagonist cetrorelix, but 
otherwise evoked a 40% increase in LH secretion (Rizwan et al., 2012). Indeed, such 
findings show potential for a cooperative GnRH and RFRP-3 intercellular signalling 
mechanism in the pituitary gonadotrophs but there is a lack of evidence that supports 
an independent hypophysiotropic effect of RFRP-3. While an explanation of species 
specific RFPR inhibitory mechanism is also  possible, the Clarke lab group also 
measured RFRP-3 in the portal blood circulation that supplies the anterior pituitary 
gland in sheep (Smith et al., 2012), but the concentrations bore no resemblance to LH 
pulses. 
 
At present, experimental evidence in the literature mainly favours a central inhibitory 
role of RFRP neurons through interactions with GnRH and kisspeptin neurons. It 
should be noted that RFRP neuronal fibres project widely throughout the brain and 
spinal cord, beyond the hypothalamic regions containing GnRH neurons (Tsutsui et 
al., 2000; Kriegsfeld et al., 2006). They are therefore likely to interact with central 
regulators of other body systems, some of which may suppress the reproductive axis 
hormone secretion.  
 
2.1.2 GnRH and LH secretion 
Due to the hypophysiotropic effect of GnRH neurons, the pattern of GnRH secretion 
is closely mimicked in LH secretion. In genetically modified mice, the direct activation 
of multiple GnRH neuron cell bodies or their distal dendrons by using the optogenetic 
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technique for 2 min at 10 Hz, was shown to generate pulse-like increments in LH 
secretion (Campos and Herbison, 2014). In female mice, the pattern of the activity 
marker Cfos expression in GnRH neurons reflects preovulatory surge serum LH 
values, with the maximum GnRH activity observed at the height of the LH surge 
(Poling et al., 2017). As GnRH is not detectable in the general circulation, the pulsatile 
and surge patterns of GnRH secretion are often investigated using LH secretion as a 
proxy. The upstream regulators of the fertility drivers GnRH and LH that aid in 
precise control of gonadal function are as follows. 
 
2.1.2.1 Pulsatile secretion 
In humans, a mutation in kisspeptin gene (KISS1) or its respective receptor KISS1R, 
has been shown to disrupt pulsatile LH secretion (De Roux et al., 2003; Seminara et 
al., 2004; Topaloglu et al., 2012). The episodic release of GnRH is specifically credited 
to stimulation from the ARC subpopulation of kisspeptin neurons that project to the 
distal dendron and terminals of GnRH neurons in and around the median eminence 
of mice (Oakley et al., 2009; Glanowska and Moenter, 2015; Yip et al., 2015). Research 
to date suggests that ARC kisspeptin neurons co-express excitatory neurokinin B 
(NKB) and inhibitory dynorphin to form an interconnected and synchronised 
neuronal ensemble that sends a periodic stimulatory signal to the GnRH neurons for 
pulsatile gonadotropin secretion (Navarro et al., 2009; Wakabayashi et al., 2010; Qiu 
et al., 2016). Due to the ubiquity of pulse generation and presence of ARC kisspeptin 
neurons in all mammalian species, this ARC kisspeptin driven pulse generation unit 
is proposed as a highly conserved central core of the GnRH neuronal network among 
mammals (Lehman et al., 2010).  
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In both male and female mice, 35% of ARC kisspeptin neurons receive projections 
from RFRP fibres (Poling et al., 2013). There is, however, limited literature that 
examines the inhibitory effect of RFRP neurons on pulsatile gonadotropin secretion. 
The few studies that have measured the effect on pulsatile LH secretion or basal 
plasma LH concentration have done so via administration of exogenous RFRP-3, and 
report contradictory findings. In ovariectomised (OVX) female mice, 
intracerebroventricular (i.c.v.) administration of 2.5 or 25 µg RFRP-3 was shown to be 
insufficient for suppressing pulsatile LH secretion (Anderson et al., 2009). 
Alternatively, the suppressive effect of 0.5 to 5 nmol i.c.v. RFRP-3 on plasma LH 
concentration has been reported in intact and castrated  male mice, but not in intact or 
OVX female mice (Ancel et al., 2017). The experiments conducted on rats show 1 nmol 
and 5 nmol RFRP-3 i.c.v. administration is capable of significantly reducing plasma 
LH concentration in both intact and gonadectomised male and female rats (Pineda et 
al., 2010). This inhibitory effect of RFRP neurons on LH secretion and pulse frequency 
has also been reported in ovine and bovine species (Kadokawa et al., 2009; Clarke et 
al., 2012). However, due to the inconsistencies with exogenous RFRP-3 treatment dose 
and variation in study design, further research is needed to understand the full 
magnitude and potentially sex-biased inhibitory effect of endogenous RFRP activity 
on pulsatile gonadotropin secretion. 
 
2.1.2.2 Surge secretion 
All spontaneously ovulating mammalian species have a common initiating signal of 
long-term elevated late follicular-phase oestradiol level acting on the hypothalamus 
and pituitary which results in a GnRH surge, and thus a LH surge (Plant, 2012). This 
is commonly referred to as the pre-ovulatory surge. Contrary to pulse generation, the 
burst in GnRH activity that is required for pre-ovulatory surge induction appears to 
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be regulated by a distinct sub-population of kisspeptin neurons primarily located in 
the anteroventral periventricular nucleus (AVPV) (Smith et al., 2006; Adachi et al., 
2007; Clarkson et al., 2008; Liu et al., 2011). Consistent with the sexually dimorphic 
presence of the GnRH surge, the AVPV kisspeptin neuronal subpopulation is 
predominantly found in females (Clarkson and Herbison, 2006). Given the importance 
of ovulation for mammalian reproduction, the GnRH neuronal network requires the 
integration of circadian signals for identifying fluctuating oestradiol levels with 
kisspeptin stimulation in order to induce the preovulatory LH surge (Williams III et 
al., 2011; Piet et al., 2013). These kisspeptin neurons project to GnRH cell bodies and 
express ERα as well as receive circadian vasopressin inputs from the suprachiasmatic 
nucleus (SCN) (Williams III et al., 2011; Poling et al., 2017). In humans, the pre-
ovulatory surge occurs in the mid to late follicular phase; in mice this corresponds to 
the proestrus phase of the oestrous cycle. Additionally, circadian signalling from the 
superchiasmatic nucleus (SCN) also ensures the time of the surge onset and thus 
ovulation is co-ordinated with sexual behaviour (Everett and Sawyer, 1950; Williams 
III et al., 2011).  
 
The inhibitory effect of exogenous RFRP-3 (0.5 nmol) on the pre-ovulatory surge when 
administered centrally, is apparent in naturally cycling proestrus mice and  OVX mice 
subjected to a pre-ovulatory-like surge oestradiol treatment (Ancel et al., 2017). 
Similarly in adult intact female hamsters, acute i.c.v. injection 30 mins before the LH 
surge significantly reduces surge amplitude in comparison to vehicle treatment 
(Henningsen et al., 2017). This suppressive effect of RFRP-3 has also been shown on 
oestrogen induced LH surges in OVX ewes (Clarke et al., 2012). It appears that unlike 
pulsatile secretion, the inhibitory effect of RFRP-3 on the LH surge is a consistent 
finding in the literature. It is reported that activity in the GnRH neuronal population 
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and in the AVPV region is suppressed by 50-80% with central administration of RFRP-
3 (Anderson et al., 2009). Although AVPV kisspeptin neuron specific inhibition of 
RFRP-3 has not yet been reported, as mentioned earlier, ~20% of these neurons 
express GPR147 receptor and thus have the cellular machinery required to interact 
with exogenous RFRP-3 (Rizwan et al., 2012; Poling et al., 2013). 
 
 The little research that examines the modulation of endogenous RFRP activity for 
adequate surge induction propose a time dependent variation in RFRP activity which 
is controlled by oestradiol and SCN signals. In OVX mice, the downregulation of the 
activity marker cFos has been measured in RFRP neurons at the time of the pre-
ovulatory surge but only in the presences of high oestradiol concentrations (Gibson et 
al., 2008; Clarke et al., 2012) . It is therefore likely that the enhanced oestradiol secretion 
that induces positive feedback on the HPG axis also modulates RFRP activity for 
adequate surge response. Further, the reports of SCN derived arginine vasopressin 
fibre projection in close apposition to RFRP neurons (Russo et al., 2015) support 
potential circadian control of RFRP neurons that is similar to the modulation of GnRH 
and kisspeptin secretion. Additionally, in OVX female hamsters, RFRP neurons are 
also shown to express the circadian timekeeping gene product Period circadian 
protein homolog 1, which is the protein product of the essential clock gene Per1 (Russo 




Figure 2.2 Hypothalamic regulation of pulsatile and surge LH secretion. The GnRH neurons 
receive projections to the cell body and proximal dendrite from AVPV kisspeptin neurons. 
These kisspeptin neurons in females integrate gonadal steroid and circadian input to induce 
burst in GnRH activity required for pre-ovulatory surge generation. The ARC kisspeptin 
neurons in both males and females, project to the distal dendron of the GnRH neuron and are 
the central pacemakers that generate pulse like increments in GnRH activity that causes 
pulsatile LH secretion. The RFRP neurons localised in the DMH project to GnRH neurons and 
to both sub-populations of kisspeptin neurons (not shown here for simplicity) and inhibit the 




2.2 Hypothalamic pituitary adrenal axis 
The endocrine stress response is regulated by the hypothalamic-pituitary adrenal axis 
(HPA). Following stimulation from a stressor, the HPA axis is activated via 
corticotropin releasing hormone (CRH) and arginine vasopressin-expressing 
hypothalamic cells located in the medial parvocellular region of the paraventricular 
nucleus (PVN). CRH is released into the hypophyseal portal blood and enters the 
anterior pituitary gland to stimulate corticotroph cells and induce adrenocorticotropic 
hormone (ACTH) secretion into the systemic circulation. ACTH then acts at the 
melanocortin receptors on the adrenal cortex to stimulate synthesis and release of the 
third hormone in this cascade of stress response, the glucocorticoids, which is 
predominantly cortisol in humans and corticosterone in rodents. Glucocorticoids play 
an important role in regulating the basal activity of the HPA axis, as well as in 
terminating stress responses by exerting their negative feedback at extrahypothalamic 
centres, the hypothalamus and the pituitary gland. The endocrine stress response is 
initiated within minutes of stimulation from the stressor whereas the magnitude and 




Figure 2.3 Schematic overview of the hypothalamic pituitary adrenal (HPA) axis. CRH 
neurons from the hypothalamus stimulates secretion of the ACTH  from the anterior pituitary 
gland. ACTH released in the general circulation acts on the adrenal medulla and stimulates 
synthesis and secretion of cortisol. Cortisol feedbacks to the hypothalamus and pituitary to 
regulate endocrine stress response. 
 
 
2.2.1 Physiological response to stress. 
Glucocorticoid receptors (GR) are ubiquitously expressed throughout the body 
enabling them to exert catabolic, lipogenic, antireproductive and immunosuppressive 
effects as well as antagonise growth hormone and bone anabolism (Dubey and Plant, 
1985; Burguera et al., 1990; Estienne et al., 1991; Magiakou et al., 1994; Rodgers et al., 
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1994; Summey and Yosipovitch, 2006; Xu et al., 2009). This collective suppression of 
other biological functions is known as the allostatic load of stress – a principal 
introduced by Sterling et al. (1988) in which the body attains a new stabilising set point 
outside the normal homeostatic equilibrium position. Energy conserved from the 
inhibition of other biological systems is diverted to enhance cognitive function and 
prioritise immediate survival of the individual.  
 
In parallel to the endocrine HPA axis response, exposure to stress also initiates the 
activation of preganglionic sympathetic neurons in the thoracolumbar spinal cord to 
stimulate the release of adrenaline and noradrenaline (Ulrich-Lai and Herman, 2009). 
This in turn redirects the energy reservoir and also elicits the classic fight-or-flight 
response required for a quick reaction to a life threatening situations. However, the 
sympathetic-medullary action, unlike glucocorticoids, is short lived and is overcome 
by the parasympathetic activity to restore overall body homeostasis (Ulrich-Lai et al., 
2000; McEwen 2000). The allostatic load of stress and sustained dyshomeostasis in the 
system is predominantly driven by the long-lasting HPA axis response (McEwen, 
2000). 
 
It is noted that stress, whether in the form of a real or perceived threat, is detrimental 
to health and may even result in death without an adequate and appropriate 
physiological response (Hart, 1988). The concomitant negative regulation of 
circulating glucocorticoids upon removal of the stressor is generally sufficient to 
reduce circulating glucocorticoids and restore overall homeostasis. Although, the 
chronic activation of stress response has an opposite effect with long term exposure 
to glucocorticoids being associated with the development of pathologies of 
neuropsychiatric disorders including depression and chronic anxiety (Levy and 
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Tasker, 2012). Chronically elevated glucocorticoid concentration also suppresses 
reproductive axis. While glucocorticoid secretion during acute stress induces a 
suppressive effect on the reproductive axis, it only acts to delay reproduction (Kinsey-
Jones et al., 2010). Persistent infertility on the other hand, is often attributed to the 
effect of chronic stress (Veldhuis et al., 1992; Tilbrook et al., 2000; Herod et al., 2011; 
Geraghty et al., 2015; Xu et al., 2017) 
 
2.3 Glucocorticoid-induced suppression of the reproductive axis 
Glucocorticoids inhibit the HPG axis at every level from the hypothalamus to the 
gonads (Whirledge and Cidlowski, 2010). Direct action of glucocorticoids on the 
gonads is possible with the presence of glucocorticoid receptors (GRs) in several cell 
populations within the gonads, including the androgen synthesising Leydig cells, 
ovarian surface epithelium, follicles and the corpus luteum (Schultz et al., 1993; Yong 
et al., 2002; Rae et al., 2004; Rae et al., 2009). However, comprehensive reviews on 
rodents, ovine species and primates suggest that the deprivation of adequate 
gonadotrophin support due to reduction in endogenous GnRH/LH secretion is the 
primary cause of gonadal dysfunction from stress (Dobson and Smith, 2000; Tilbrook 
et al., 2000; Whirledge and Cidlowski, 2010).  
 
Studies that investigate the correlation between the central effect of stress and causes 
of infertility, often model a psychosocial stress response in experimental animals via 
restraint, isolation or by simply administering high doses of exogenous 
glucocorticoids. In OVX ewes, psychosocial stress induced through a combination of 
isolation and restraint was shown to suppress both GnRH pulse amplitude and LH 
pulse amplitude (Breen et al., 2007; Wagenmaker et al., 2009). While no effect on LH 
pulse amplitude was reported with restraint in OVX mice by Yang et al. (2017), this 
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study reported a 60% and 40% reduction in LH pulse frequency and basal LH levels, 
respectively. Similarly in rats and ewes, enhanced glucocorticoid secretion induced by 
immobilisation stress resulted in the suppression of GnRH-dependent LH pulse 
frequency (Tilbrook et al., 1999; Li et al., 2004). Also, suppression of the preovulatory 
LH surge in proestrus rats and ewes is more prominent with the induction of 
psychogenic stress (Martin et al., 1981; Roozendaal et al., 1997).  
 
Inhibition of pituitary function by glucocorticoids can occur by modulating GnRH 
receptor expression to alter sensitivity/responsiveness to GnRH secretion and by 
decreasing gonadotropin secretion from the gonadotroph cells (Breen et al., 2008). 
Gonadotroph cells express GRs, although the direct effect of glucocorticoids on 
pituitary function are observed to be highly variable. A possible reason may be the 
different endpoints measured (LH secretion or the abundance of its gene expression) 
and the duration of the stress response. Daily corticosterone administration along 
with immobilisation stress has been shown to reduce mRNA expression of 
glycoprotein subunits that assemble to form LH and FSH in gonadotrophs (Breen et 
al., 2012). The LHβ subunit contains a corticosterone-responsive promoter region, thus 
indicating a possible direct regulation of glucocorticoid on LH synthesis by 
glucocorticoids (Breen et al., 2012). In another much older study, chronic 
immobilisation was shown to reduce plasma LH levels despite increased pituitary 
levels of LH and FSH (Du Ruisseau et al., 1979). It appears that the synthesis of 
gonadotropins may not always match their secretion, and that gonadal failure 
observed in chronic stress is due to the dampened gonadotropin secretion - rather 
than synthesis - from the pituitary. More emphasis on conducting research on stress-
induced inhibitory mechanisms of the gonadotrophs will help better understand 
interactions inducing LH suppression in infertility.   
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Regardless of the type of stressor, the core HPA axis response of elevating 
glucocorticoids in circulation, resulting in disruption of the HPG neuroendocrine 
activity, remains a consistent response. Peripherally administered glucocorticoid 
receptor antagonists, however, have been insufficient in overcoming the suppressive 
effect on the HPG axis (Breen et al., 2007; Wagenmaker et al., 2009). Therefore, central 
neuronal and hormonal interaction between the HPG and HPA axes must also play a 
primary role in mediating the chronic glucocorticoid-induced suppression of 
gonadotropin secretion. 
 
2.4 Hypothalamic interplay between the HPG and HPA axes 
In the hypothalamus, CRH has two receptor subtypes (CRHR1 and CRHR2); stress-
induced LH suppression was prevented in rats with CRH1 blockade whereas CRHR2 
blockade was shown to only partially allow LH suppression (Li et al., 2005; Li et al., 
2006; Kinsey-Jones et al., 2010). It remains controversial whether GnRH neurons 
express CRH receptors, as 25% of CRH receptor expression on GnRH neurons has 
been reported for adult female mice, but no expression in male mice (Jasoni et al., 2005; 
Raftogianni et al., 2018). Others have suggested that only a strikingly small fraction of 
GnRH neurons express GRs (Dufourny and Skinner, 2002). Experimental evidence 
from the ovine males and females suggests that CRH and glucocorticoids mediate 
their reproductive suppressive effect from other interneuronal pathways (Rivalland 
et al., 2006). The possibility of interneuronal pathways is also suggested by the patch-
clamp electrophysiological recording done by Raftogianni and colleagues on the brain 
sections  of CRH1 knock-out mice and wild type mice which showed no difference in 
GnRH activity upon CRH application (Raftogianni et al., 2018).  
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Central stress-induced reproductive axis suppression has been suggested to occur via 
the inhibition of afferent GnRH excitatory kisspeptin neurons and upregulation of the 
GnRH inhibitory RFRP neurons (Iwasa et al., 2008; Kinsey-Jones et al., 2010). The 
upstream kisspeptin neurons of the ARC and AVPV express CRH receptors and GRs, 
suggesting they might be able to respond to either hormones and inhibit downstream 
secretion of GnRH/LH pulses and the surge (Takumi et al., 2012). Supporting the 
indirect inhibition of GnRH neurons by glucocorticoids, immunohistochemical 
analysis of mouse brains shows a potent decrease in ARC Kiss1 neuronal activation as 
measured by Cfos induction, and an increase in the endogenous Rfrp neuronal activity 
in both male and female mice in response to 3 h of restrain stress (Yang et al., 2017; 
Yang et al., 2018). There is some opposing evidence in ewes in which immobilisation 
stress stimulation did not alter hypothalamic RFRP cell activity. However, in this 
study there was only modest suppression of LH, indicating that the circulating 
glucocorticoid levels were perhaps not high enough to stimulate RFRP neurons and 
suppress gonadotropin release (Papargiris et al., 2011). The mechanisms that mediate 
glucocorticoid and CRH action on the HPG axis are not yet fully understood. 
 
2.4.1 RFRP as a modulator of stress responses  
Previous studies on the chronic stress response have shown that negative feedback 
from glucocorticoids is insufficient to suppress CRH neuronal activity (Makino et al., 
1995; Kim et al., 2019). Indirect regulation of the PVN via other hypothalamic nuclei 
has been hypothesised to disrupt the negative HPA axis feedback loop (Sawchenko et 
al., 1993). Central administration of RFRP-3 has been shown to elevate circulating 
corticosterone levels in mice and this effect was counteracted with the administration 
of the GPR147 antagonist GJ14 (Kim et al., 2015). Such findings provide a compelling 
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evidence for a potential role of RFRP outside the reproductive system, enhancing the 
endocrine stress response.  
 
The robust inhibitory effect of GABA signalling is also an important regulator of CRH 
excitability (Wamsteeker and Bains, 2010; Lee and Maguire, 2014). In hypothalamic 
slice patch-clamp recording from mice, application of RFRP-3 dampened the 
frequency of inhibitory postsynaptic currents to the parvocellular PVN neurons in a 
dose dependent manner, and the inhibitory effect was abolished in the presence of 
competitive GABA antagonist (Jhamandas et al., 2007). This study did not verify 
whether the inhibitory effect was specifically in CRH or AVP neurons. Another study 
has reported around 30% of CRH neurons express the GPR147 receptor, and there is 
extensive projections of RFRP-3 reactive fibres in the PVN (Liu et al., 2001). Contrary 
to the prominent inhibitory role of RFRP neurons discussed thus far, Jhamandas et al. 
(2007) via patch clamp recording showed depolarisation of the parvocellular PVN 
neuron upon RFRP-3 application in the bath solution. CRH depolarisation was 
sustained in response to repeated application of RFRP thus showing lack of 
desensitisation to RFRP signalling. RFRP neurons may therefore prevent attenuation 
of glucocorticoids secretion by either eliciting a direct activation of CRH neurons or 
by attenuating inhibitory GABA input.   
 
Emerging research into the interaction of RFRP neurons and CRH neurons is 
suggestive of glucocorticoid-dependent activation of RFRP neurons during chronic 
stress. Dexamethasone (a GR agonist) is shown to increase Rfrp and Gpr147 transcripts 
in immortalised hypothalamic cells in vitro (Gojska and Belsham, 2014). 
Immunohistochemical staining in mice brain sections has revealed GR expression in 
53% of RFRP neurons (Kirby et al., 2009). Additionally, in mice, chronic and acute 
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immobilisation stress is shown to upregulate  Rfrp expression which was counteracted 
by adrenalectomy (Kirby et al., 2009). The presence of two glucocorticoid response 
elements (GREs) has also been reported on the Rfrp promoter region for the rat gene 
(Son et al., 2014). These findings position RFRP neurons as a possible mediators of 
stress-induced HPA axis activation as well as suppression of the HPG axis, either by 





Figure 2.4 Schematic representation of the hypothalamic interplay between neurons of the 
HPG and HPA axis. There is limited evidence for the direct inhibition of the primary 
reproductive axis driver, GnRH neuron, by the stress axis modulator, CRH neuron (presented 
by the dotted line). Instead, literature suggests that tonically active CRH neurons (partially 
regulated via SCN stimulation; Watts et al., 2004) rapidly respond to stress and inhibit the 
ARC and AVPV kisspeptin that are required for the GnRH pulses and surge secretion, 
respectively. The reproductive inhibitory effect of RFRP neurons that may be minimised with 
SCN input (Russo et al., 2015) under basal conditions, is upregulated during the stress 
response to suppress GnRH neurosecretion as well as the ARC and AVPV kisspeptin 
neurosecretion. Collectively, these physiological processes deprive gonads of gonadotropins 
which results in reproductive dysfunction. RFRP neurons further enhance stress induced 
reproductive suppression by stimulating CRH neurons (Jhamandas et al., 2007) and thereby 
enhancing the endocrine stress response. Therefore, RFRP neurons are proposed as the crucial 
link in the neurocircuitry regulating the stress-induced suppression of the HPG axis. 
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2.5 RFRP neurons, stress and fertility 
There are only a few studies in mammals that have looked at the correlation of all 
three: stress, fertility and the effect of RFRP neurons. In such studies it is consistently 
noted that, as mentioned earlier, chronic stress increases hypothalamic RFRP neuronal 
activity levels, and this correlates with downstream suppression in gonadotropin 
secretion for both male and female rodent species (Kirby et al., 2009; Iwasa et al., 2014). 
This suggests an inhibitory role of RFRP neurons for suppression of the HPG axis 
during stress, although it remains unknown whether hyperactivity in the RFRP 
neuronal population is sufficient to suppress the HPG axis.  
 
Where the effect of RFRP neuronal hyperactivity is modelled, research is limited to 
the use of exogenous RFRP-3 i.c.v. administration (Han et al., 2017). In these studies 
oestrous cycle stage dependent suppression is observed, where plasma LH 
suppression is observed in proestrus and not in dioestrus female mice (Ancel et al., 
2017). However, stress has been shown to elevate hypothalamic Rfrp expression in all 
stages of the oestrous cycle (Geraghty et al., 2015). Although adult male rats are 
reported to have dose-dependent suppression of plasma LH with i.c.v. RFRP-3 
administration, no effect was seen on plasma corticosterone levels (Johnson et al., 
2007). To clarify the effectiveness of enhanced RFRP activity seen during stress 
responses, there is a requirement of an in vivo experiment where the effect of 
endogenously hyperactivated RFRP neurons on gonadotropin secretion is measured. 
 
The most striking causative observation to date in regards to the effect of stress-
induced endogenous Rfrp upregulation on reproductive suppression comes from the 
shRNA-mediated knock-down of Rfrp in the DMH (Geraghty et al., 2015). Here, 
downstream reproductive dysfunction (i.e fewer copulatory events, lower pregnancy 
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rates and decreased litter size) was noted in female rats experiencing chronic 
immobilisation stress and upregulated Rfrp expression, and this was found to be 
absent in the RFRP knock-down rats. This study remains unique in showcasing the 
surprising requirement for RFRP neurons in supressing fertility in females, but such 
reproductive effects from endogenous RFRP activity modulation in males remain to 
be tested. Given the sexual dimorphism of HPG axis and lower susceptibility to stress 
by males, the magnitude of the effect of RFRP neuronal modulation is needed to be 
assessed in both sexes. 
 
From the current understanding of the literature it can be hypothesised that 
suppressing RFRP neuronal activity in chronic stress conditions can restore 
homeostasis to HPG axis function. This is the focus of this thesis, and methods of fine-
tuning RFRP activity and its effect will be tested in both females and males. 
 
2.6 Chemogenetic approach to neuronal manipulation 
An approach to controlling the activity of individual neuronal populations that has 
become increasingly used over the last decade is the use of the DREADDs (designer 
receptors exclusively activated by designer drugs). DREADDs are a mutant of  G 
protein coupled muscarinic receptors. They were developed using direct evolution in 
a yeast mutagenesis system to lose the ability to respond to the natural ligand 
acetylcholine and gain the ability to specifically respond to an otherwise inert 
compound clozapine-N-oxide (CNO; Figure 2.5). These mutant receptors show low 
basal activity and thereby provide a dynamic range for agonist-induced responses 
(Armbruster et al., 2007). The two variants of DREADDs used in this study are Gi-
coupled human M4 muscarinic DREADD (hM4Di) and Gq-coupled human M3 





Figure 2.5 Schematic representation of designer receptors exclusively activated by 
designer drugs (DREADDs). Both DREADD contain Y3.33C and A5.46G point mutation in 
TM3 and TM5 which result in the loss of binding affinity, potency and efficacy to 
acetylcholine (Ach). Concomitantly these mutations are reported to induce conformational 
rearrangements that are favourable to CNO binding. (Wess et al., 2013). 
  
 
Characterisation of the molecular pathway underlying DREADD function shows 
hM4Di mediated neuronal silencing, involve induction of hyperpolarisation by the 
Giβγ-mediated activation of G protein-coupled inwardly-rectifying potassium 
channels (Armbruster et al., 2007). Alternatively, hM3Dq-mediated neuronal 
excitation is dependent on depolarisation caused by the Gq-mediated activation of 
phospholipase (Alexander et al., 2009). Expression of hM4Di and hM3Dq has been 
shown to successfully manipulate the firing rate of neurons of the CNS (Figure 2.5). 
Application of DREADD technology is readily utilised with Cre driver mouse lines to 










Figure 2.6 CNO dependent activation of hM4Di and hM3Dq DREADDs. 
Electrophysiological recording of mouse hippocampal pyramidal cell on coronal brain 
sections of mice. A. Recordings from hM4Di expressing mice show the resting membrane 
potential is decreased with CNO (1 and 10 µM)  application (Zhu et al., 2014). B. Recordings 
from an hM3Dq cell (DREADD positive) before CNO application. A 100 pA current does not 
elicit action potentials on its own, but the same current is able to elicit neuronal firing once 
CNO is applied to the bath. The control (DREADD negative cell)  shows no response to the 
100 pA current even in the presence of CNO (Vasquez et al., 2019).  
 
2.6.1 Cre-dependent DREADD expression 
Cre-dependent expression is determined by Cre-LoxP transgenics which facilitate the 
ability to specifically manipulate expression of various proteins on individual cell 
types. Cre-lox technology requires the expression of Cre recombinase, an enzyme that 
catalyses recombination between loxP sites, in the cells that are to be manipulated. 
Here, the targeting construct placing hM3Dq and hM4Di under control of the strong 
ubiquitous CAG promoter is separated from the DREADD coding sequence by a 
transcription blocker ‘STOP’ cassette that is ‘floxed’ i.e flanked by loxP sites (Sauer 
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1998). With the aid of the Cre recombinase enzyme selectively expressed in the 
targeted neurons, the stop signal is removed, and promoter region is exposed to allow 




Figure 2.6 use of the Cre-lox transgenic system to express DREADDs. Shown here is the 
example of the inhibitory DREADD hM4Di sequence. The loxP-sites surround a transcription 
blocker sequence stop signal which lies downstream of the ubiquitous CAG promoter but 
upstream of the DREADD coding sequence. As such, DREADD expression is restricted to 
only cells that express the Cre recombinase enzyme that is capable of excising the ‘floxed 
STOP cassette’ and therefore results in cell type-specific DREADD expression. Each DREADD 






The overall aim of this thesis is to assess whether  RFRP neurons modulate 
glucocorticoid-induced suppression of the reproductive axis. Previous research is 
limited in supporting direct interaction between central regulators of the  HPG and 
HPA axes. However, evidence to date suggests RFPP neurons are a likely candidate 
as an intermediary neuronal link between these axes. With the use of Cre-dependent 
DREADD expression in RFRP neurons, endogenous RFRP activity can be 
manipulated in vivo so their effect on mediating glucocorticoid-induced suppression 
of the HPG axis function can be characterised. Utilising this advancement in 
chemogenetic technology to study neuronal interaction, the two specific aims of this 
study are: 
 
1. To test if hM4Di receptor-mediated suppression of RFRP neuronal activity 
can restore normal LH secretion following glucocorticoid treatment. 
 
2. To test if hM3Dq receptor-mediated hyperactivation of RFRP neurons will 
increase circulating glucocorticoid concentration and suppress LH 
secretion.  
 
Together, these experiments will enable me to establish if RFRP neuronal activity is 







3.1 Animal housing  
All mice were obtained from the University of Otago animal breeding facility at 5 
weeks old. These animals were group housed in individually ventilated cages with a 
maximum of 3 mice in each cage. Mice were fed standard mice chow and access to 
both food and water was available ad libitum. Temperature of the room was kept 
constant at 22 ± 1 °C and a light/dark cycle was maintained with 12 h of each (lights 
on between 0700 h and 1900 h; blood sampling conducted during the first half of the 
light phase). For hormonal sampling experiments, all mice were habituated to daily 
handling for at least one week prior to blood collection. All experiments were 
conducted in adult mice around 8-10 weeks of age. The animal experimentation 
protocol used in this study was approved by the University of Otago Animal Ethics 
Committee. 
 
3.2 Generation of RFRP Cre-DREADD mice 
C57BL/6 background strain mice were used as a model for human HPG and HPA 
axis function. The Rfrp-Cre conditional knock-in mice were first generated using 
homologous recombination in mouse embryonic stem cells (Beglopoulos and Shen, 
2004) by Ozgene (Western Australia), so that the knock-in allele produced a bicistronic 
Rfrp (the gene encoding RFRP peptides) and Cre mRNA. The targeting vector 
consisted of 5' and 3' sequence arms (~4 and ~6 kb in length respectively) that were 
homologous to the Rfrp gene and included an internal ribosomal entry sequence 
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(IRES) linked to Cre recombinase and a FRT-flanked neomycin resistance gene. The 
IRES and Cre sequence was targeted into the 3’ untranslated region on exon 3 that is 
immediately downstream of the termination codon within the Rfrp gene (NCBI 
database Gene ID: 60531; Ensemble gene report ID: ENSMUSG00000029831). 
Completed constructs (Figure 3.1 A) were electroporated into Bruce4 C57BL/6 
embryonic stem cells, and then chimeric mice were generated using blastocyst 
manipulation techniques. Chimeric mice were bred to C57BL/6 mice to identify germ-
line transmission of the targeted gene, and then FLPe-deleter mice used to remove the 
FRT-flanked neomycin selection cassette (Dymecki and Tomasiewicz, 1998). Cre 
expression restricted to RFRP neurons has been validated by Prof Greg Anderson’s 
research group by crossing these mice to tau-green fluorescent protein (GFP) gene 






Figure 3.1 Validation of RFRP specific Cre expression. A. RFRP gene integrated with Cre 
expression. The internal ribosomal entry sequence upstream (IRES) of Cre aids in translation 
of Cre recombinase enzyme expression in RFRP cells. B. Representative images showing 
RFRP-Cre-GFP expression in the dorsal medial hypothalamus. Approximately 80% of GFP-
expressing cells co-expressed RFRP-3 immunolabeling in both male and female mice, and a 
similar percentage of RFRP-3 cells expressed GFP (n=6 per group; Mamgain et al., 2020). 
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The heterozygous RFRP-Cre mice were crossed with heterozygous inhibitory hM4Di 
flox mice (hM4Di-DREADD mice, Jax strain 026219), and another set of heterozygous 
RFRP-Cre mice were crossed with heterozygous excitatory hM3Dq flox mice (hM3Dq-
DREADD mice, Jax strain 026220). For RFRP-Cre x hM4Di mice, an additional 
generation of breeding was conducted to generate homozygous mice for hM4Di. 
Following Cre-mediated removal of the polyA STOP cassette, expression of hM4Di 
and hM3Dq is observed (Figure 3.2). Binding of the hM4Di receptor by CNO induces 
the canonical Gi pathway; leading to RFRP silencing of neuronal activity whereas 
binding of the hM3Dq receptor by CNO induces the canonical Gq pathway; leading 
to RFRP neuronal activity/neuronal firing.  
 
Offspring expressing both an RFRP-Cre and an hM4Di-DREADD allele became the 
‘knock-in’ treatment (RFRP-hM4Di) mice, while Cre-positive, hM4Di-DREADD-
negative and Cre-negative, hM4Di-DREADD-positive mice were used as control 
animals so that any potential adverse effect of Cre expression could be assessed. 
Similarly, offspring expressing both an RFRP-Cre and an hM3Dq-DREADD allele 
became the ‘knock-in’ treatment (RFRP-hM3Dq) mice, while Cre-positive, hM3Dq-
DREADD-negative and Cre-negative, hM3Dq-DREADD-positive mice were used as 
control animals. The DREADD agonist CNO has been reported to be without non-
specific effects in C57BL/6 mice at doses of up to 5 mg/kg (Alexander et al., 2009; 









Figure 3.2 Schematic illustration of the use of Cre-LoxP chemogenetic technique to isolate 
DREADD expression in RFRP neurons. A. Double transgenic mice were created by mating 
RFRP-Cre mice with DREADD expressing mice. Recombination of the floxed DREADD gene 
occurs only in offspring that have Cre expression. In this thesis, RFRP-hM4Di mice were used 
to test aim 1 and RFRP-hM3Dq mice were used to test aim 2. B. Representative 
immunolabelled images from RFRP-hM3Dq mice. 90.2±1.6% of RFRP-3 neurons coexpressed 
the DREADD tagged mCitrine (n=5 per group). The distribution of mCitrine was confined to 
the DMH as described above for tau-GFP, but only 40.0±7.3% of all mCitrine-labelled cells co-
expressed RFRP-3; this is consistent with the previously-described loss of Rfrp expression in 
some cells during pre-pubertal development (Poling et al., 2012). (Mamgain et al., 2020) 
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To understand the effect of RFRP manipulation on the glucocorticoid-induced 
suppression of the reproductive axis, experiments were initially designed to measure 
the effect on both pulsatile (Experiment A) and surge secretion (Experiment B) of LH. 
This would enable understanding of the magnitude and effectiveness of endogenous 
RFRP on the HPG axis hormone secretion pattern for stress-induced infertility. Details 
for all procedures and treatments mentioned in the experiment design below are 
described in section 3.4. 
 
3.2.1 Experiment A: Effect of corticosterone on the LH surge 
To test whether endogenous RFRP activity is required and is sufficient for 
glucocorticoid-induced suppression of LH surges, a methodology for corticosterone 
delivery and protocol for LH surge assessment was tested. Two sets of surge models 
were assessed: a proestrus pre-ovulatory LH surge in regularly cycling intact female 
mice and an exogenous oestradiol-induced LH surge in bilaterally overectomised 
(OVX) mice. The efficiency of these surge protocols was initially assessed only in 
control female mice as a pilot for the actual DREADD experiment.  
 
i. Intact female mice: proestrus pre-ovulatory LH surge 
The cytological examination of vaginal smears for intact female mice was documented 
for each animal as described in section 3.4.2.  Female mice exhibiting regular 4-5 day 
oestrous cycles within a 21-day period of prior monitoring were included in this 
experiment. On the day of the following proestrus, tail tip blood samples were 
collected to identify the pre-ovulatory LH surge. In mice, a pre-ovulatory LH surge 
occurs in late afternoon on the day of proestrus to synchronise ovulation with mating 
several hours later at oestrus. Baseline LH blood samples were collected at 1100, 1400 
and 1700 h, and to capture the LH surge three blood samples were collected an hour 
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before lights out at 1800, 1830 and 1900 h (section 3.4.3.1). To elevate the circulating 
glucocorticoid levels without disrupting oestrous cyclicity leading up to proestrus, 
corticosterone was administered only on the day of proestrus. In the treatment group, 
a 1 mg/kg subcutaneous (s.c.) corticosterone injection (section 3.4.4.2) was given after 
collection of the each 1100, 1400 and 1700 h blood samples to sustain stress-like 
elevated glucocorticoid levels throughout much of the day of the expected LH surge 
(Figure 3.3). The control group received a saline injection at the same time points. A 
methodology was established in section 3.4.6.2 which enabled corticosterone 
measurement from the leftover diluted blood samples after removal of some for LH 
analysis. The 1100 h sample was used as the measure of basal corticosterone 
concentration whereas samples between 1400 and 1900 h were used to analyse overall 
changes in circulating corticosterone concentration between the treatment groups.  
 
Figure 3.3 Timeline for measuring the effect of circulating glucocorticoids on the pre-
ovulatory LH surge in intact proestrus female mice. Both, saline as treatment control and 
corticosterone were delivered subcutaneously. Red boxes represent time of tail tip blood 
sample collection. 
 
ii. Ovariectomised mice: oestradiol-induced LH surge 
The methodologies from Christian et al. (2005) and Luo et al. (2016) were used to 
artificially induce an LH surge in OVX mice with the administration of a s.c. 0.625 µg 
oestradiol implant (section 3.4.4.3). These oestradiol implants have been reported to 
induce a diurnal pattern in blood LH concentration similar to the naturally occurring 
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preovulatory LH surges in mice, and exhibit the highest surge concentration of ~5 
ng/ml on day 3 of implantation (Christian et al., 2005). Chronic stress-like 
glucocorticoid levels in the circulation were delivered using in-house made ~100 mg 
s.c. corticosterone implants (section 3.4.4.3) that were developed based on a study by 
Luo et al. (2016). 
 
In order to measure the effect of the endocrine stress response on the LH surge, the 
control female mice that were habituated to repeated blood sampling protocols were 
divided into 3 groups: no implant mice, oestradiol implant only and mice with both 
oestradiol and corticosterone implants. All mice underwent a bilateral ovariectomy at 
1600 h on day 1 and were simultaneously administered with s.c.  steroid implants 
(section 3.4.5). These mice were allowed to recover on day 2, and LH blood samples 
were collected on day 3 as per the above protocol: every 3 h for basal LH concentration 
(1100, 1400 and 1700 h) and in the hour before lights out (1800, 1830 and 1900 h) for 
surge measurements. After LH surge sampling, a final blood sample was collected at 
1900 h for each animal in all 3 groups to measure circulating corticosterone 
concentration (section 3.4.3.3) in order to determine the effectiveness of the s.c. 
corticosterone implants in emulating a physiological endocrine stress response. Mice 
were monitored daily on days 1-3 for changes in body weight and vaginal cytology to 
elucidate the potential effect from oestradiol and corticosterone treatment. The no 
implant group allowed identification of basal LH in the absence of sex and chronic 
stress steroid feedback. The oestradiol treated mice and oestradiol + corticosterone 




Unfortunately, both LH surge models were ineffective in producing an LH surge high 
enough to measure the suppressive effect of exogenous corticosterone and these 
experiments never reached the RFRP manipulation stage. 
 
3.2.2 Experiment B: Effect of endogenous RFRP activity on chronic 
glucocorticoid-induced LH pulse suppression 
Due to the increased handling required for repetitive blood sampling for LH pulse 
measurements, all mice in this experiment were habituated for 30 days with their tails 
gently massaged for several mins daily. Body weights of both male and female mice 
were measured at 0800 h, and vaginal smears for female mice were also gathered 
(section 3.4.2) to monitor progression of the 4-5 day long oestrous cycle. For females, 
literature shows that pulsatile LH secretion varies within phases of the oestrous cycle 
(Czieselsky et al., 2016; McQuillan et al., 2019) so to standardise the hormonal 
environment as much as possible, blood sampling for both basal conditions and under 
the effect of glucocorticoids on LH were measured during dioestrus.  
 
3.2.2.1 B1. Are RFRP neurons required for glucocorticoid-induced neuroendocrine 
suppression of pulsatile LH secretion? 
As per aim 1, if RFRP neurons are required for glucocorticoid-induced suppression of 
LH pulses, silencing endogenous RFRP activity should restore normal LH pulsatility 
in both male and female mice exhibiting the chronic endocrine stress response. Here, 
RFRP-hM4Di mice were used to silence endogenous RFRP activity, and control mice 
(described in section 3.2) were included for comparison of LH secretion under normal 
RFRP activity with and without glucocorticoid implant treatment. Each mouse in the 
RFRP-hM4Di and control group was used as its own control for basal pulsatile LH 
secretion and in the presence of glucocorticoids. For this, a pulsatile LH secretion 
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profile was established under basal corticosterone conditions for each CNO-treated 
control and RFRP-hM4Di mouse prior to subjecting them to corticosterone treatment. 
A detailed experiment timeline for both male and female mice is illustrated in Figure 
3.4.   
 
Figure 3.4 Timeline of experiment B1. Each animal underwent repetitive tail tip blood 
sampling twice, 2 mg/kg CNO (yellow) was administered subcutaneously prior to blood 
sampling on both days. The 1st LH pulse bleed on day 1 was utilised as an indication of 
pulsatile LH secretion under basal corticosterone condition. The 2nd LH pulse bleed on day 4 
was used to characterise the suppressive effect of chronic stress-like corticosterone treatment. 
Purple represents a single blood sample taken for corticosterone measurement at 0900 h. Red 
represents repetitive tail tip blood sampling with a 4 µl sample collected every 6 mins. Green 
shows exogenous corticosterone treatment sustained via administration of subcutaneous 
corticosterone implant. 
 
At 0930 h ~0.5 mm tail tip was snipped, and a basal corticosterone sample was 
collected. Both control and RFRP-hM4Di animals were then injected with CNO (s.c. 2 
mg/kg; dose based on preliminary experiment, see Appendix C). After 30 mins, a 3 h 
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long serial blood sampling from tail tip was then commenced between 0930-1230 h for 
LH measurements (section 3.4.3.2). At 1500 h, all animals received a ~100 ng s.c. 
corticosterone implant (3.4.4.3). Animals were monitored on the following days for 
potential post-surgical complications. Their bodyweight was recorded daily and 
females were smeared every day to detect potential effects of exogenous 
corticosterone on oestrous cyclicity. Also, a single corticosterone sample (section 
3.4.3.3) was collected at 0900 h every day to measure the efficacy of s.c. corticosterone 
implants in maintaining stress-like glucocorticoid levels in the circulation throughout 
the course of this experiment.  
 
To measure the effect of glucocorticoid on LH pulses in RFRP-hM4Di and control 
mice, animals were subjected to a second blood sampling on day 4 of corticosterone 
implantation for males, and day 4-5 for females – depending on the occurrence of 
dioestrus after implant administration. Animals were subjected to the same blood 
sampling protocol for corticosterone and LH measurement as day 1. At 1500 h on the 
day of second pulse bleed, animals were culled, and their brains were collected for 
immunohistochemical staining to quantify RFRP neuronal activity in control and 




3.2.2.2 B2. Are actions of endogenous RFRP hyperactivity sufficient for 
neuroendocrine suppression of pulsatile LH secretion? 
To test whether hyperactive RFRP signaling, which as has been reported to occur 
during stress exposure, is sufficient to suppress pulsatile gonadotropin secretion, 
transgenic RFRP-hM3Dq mice were used. A control group (described in section 3.2) 
was also included. First, to control for the effect of CNO, an LH pulsatile secretion 
profile (section 3.4.3.2) under basal endogenous RFRP activity was characterised for 
each animal 30 mins post saline injection (day 1). On day 4 for males and the following 
dioestrus for females, animals were given a 2 mg/kg s.c. CNO injection (section 
3.4.4.1) and were again subjected to 3 h of repetitive tail tip blood sampling to 
characterise the effect of hyperactive RFRP neurons on LH secretion. The effects of 
CNO on corticosterone secretion were characterised to confirm the biological 
effectiveness of RFRP activation. For this, an additional blood sample was also taken 
for corticosterone measurement (section 3.4.3.3) 30 mins post saline or CNO injection, 
and again after repetitive tail tip blood sampling for LH. See Figure 3.5 for a detailed 
timeline of treatment and blood sample collection. All mice were culled on the day of 
the second pulse bleed and their brains were collected to compare 





Figure 3.5 Timeline for experiment B2. Each animal underwent repetitive tail tip blood 
sampling twice. The 1st LH pulse bleed on day 1 was utilised as an indication of pulsatile LH 
secretion under basal RFRP activity. Saline was subcutaneously injected at 0900 h. At 0930 h 
a single excision was made on the tail tip and a blood sample for corticosterone measurement 
was collected. This was followed by a repetitive tail tip blood sampling as described in section 
3.4.3.2 to measure pulsatile LH secretion. On day 4, animals were given 2 mg/kg CNO 
following which the blood samples were collected to characterise the effect of enhanced 




3.3 Experiment procedures and treatments 
 
3.3.1 Genotyping 
3.3.1.1 Tissue lysis and DNA extraction 
To genotype offspring of the RFRP-Cre crossed with DREADD mice, ~1 mm of tail tip 
was snipped from each animal to collect DNA. In a 1.7 ml Eppendorf tube, the tail tip 
was added to a mixture of 0.6 ml lysis buffer (see Appendix A for buffer recipes) and 
5 µl proteinase K. To ensure tissue digestion, samples were placed in a heating block 
at 55 °C for 8 h. Undissolved hair and bone in the samples were separated by 8 mins 
centrifugation at 20000 x g at room temperature and the supernatant was transferred 
into another Eppendorf tube containing 0.6 ml of isopropanol. This sample was 
centrifuged again for 5 mins at 20000 x g at room temperature to form a DNA pellet; 
supernatant was discarded. The DNA pellet was re-suspended in 300 µl of Tris-
acetate-EDTA (TE) buffer (Appendix A) and dissolved by incubation at 55 °C for 1 h. 
Lastly, the DNA sample was vortexed and either stored at -20 °C or it was 
immediately proceeded to PCR. 
 
3.3.1.2 Polymerase chain reaction  
The PCR mastermix was prepared with 2.5 µl of Reddymix (Thermo Fisher Scientific), 
0.5 µl of each forward and reverse primer (10 µm diluted in H2O) and 9.5 µl of distilled 
water.  Primer sequences for Cre recombinase, hM4Di and hM3Dq are listed in Table 
3.1. For each sample, 23 µl aliquots of PCR mastermix was added to 2 µl of tail DNA 
in the PCR tubes. A negative control was used where instead of the DNA template, 2 
µl of distilled water was added to the 23 µl of mastermix. A wild-type control was 
included in each run. As positive controls, two tubes with confirmed DREADD 
heterozygous and homozygous DNA were included. The PCR reactions were then 
run in a programmed PCR machine (Mastercycler Nexus, Eppendorf) to amplify DNA 
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in the following steps: 95 °C for 3 min, 55 °C for 1 min, 95 °C for 30 secs x 35 cycles, 72 
°C for 45 secs. Lastly samples were cooled at 4 °C.  
 
Table 3.1 Specific primers used for polymerase chain reaction. (bp = base pairs, wt =wild 
type) 
PCR 









Fwd: CCT GGA AAA TGCC TTC TGT CCG 
Rev: CAG GGT GTT ATA AGC AAT CCC 
 
IntCtrl1: CTA GGC CAC AGA ATT GAA AGA TCT 
IntCtrl2: GTA GGT GGA AAT TCT AGC ATC ATC C 











wt = 300bp 




wt = 300bp 
 
 
3.3.1.3 Agarose gel electrophoresis 
A 1.5 % agarose gel was made by adding 80 ml of TE (Appendix A) to 1.2 g of agarose 
and the mixture was briefly brought to a boil. This mixture was cooled to 60 °C and 
0.03 µl/ml of ethidium bromide (Roche Diagnostics, GmbH) was added. After leaving 
the gel to set at room temperature, it was then placed in an electrophoresis chamber 
and filled with Tris-borate EDTA (Appendix A). In order to determine base pair size 
of the samples, 5 µl of 100 bp graduation DNA ladder (Bioline, catalogue #33054) was 
loaded in the first well and 10 µl of amplified DNA from PCR were added to each of 
the following wells. The gels were then run at 90 V for approximately 40 mins. Upon 
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completion, the gels were visualised using an ultraviolet gel imaging chamber 
(BioDocAnalyse, Biometra) and the bands were manually analysed to detect the 
presence of Cre and DREADD alleles (Appendix B). 
 
3.3.2 Female reproductive cyclicity assessment by vaginal cytology 
The oestrous cycle of female mice was monitored by daily cytological examination of 
vaginal smears done by lavage, between 0800 h and 0900 h. Specific stages of the 
oestrous cycle were determined by studying changes in morphology of the epithelial 
cells lining the vaginal wall as described in Figure 3.2. Using a pipette, 4 µl of saline 
was expelled at the entrance of the vaginal canal and then aspirated back into the 
pipette tip to collect the epithelial cells. This epithelial cell-containing saline was 
transferred onto a microscope slide and once dry, was histochemically stained with a 
drop of 0.05% toluidine. Stained smears were assessed under a light microscope 
(Olympus BH) at 100x magnification (Figure 3.6). A 30-day smear profile was 
recorded for each mouse and those with regular oestrous cycles in subsequent order 












Figure 3.6. Representative smears of each stage of the mouse oestrous cycle. A. Proestrus is 
characterised by abundant nucleated epithelial cells. B. Oestrus is characterised by presence 
of cornified squamous epithelial cells, often in clusters. C. Metoestrus is predominantly filled 
with leukocytes and lastly, D. Dioestrus is the recovery phase when estrogen levels are lowest 
in the reproductive tract and is thus characterised with a smear containing sparse mixture of 
leukocytes, nucleated cells and cornified epithelial cells. Note LH surge samples were 
collected in proestrus and LH pulse samples were collected in dioestrus. 
 
3.3.3 Blood sample collection 
3.3.3.1 Preovulatory LH surge measurement 
Due to high concentrations of LH observed during a surge, 4 µl of tail tip blood sample 
was collected at each time point and diluted in 150 µl of 0.05% Phosphate Buffered 
Saline‑Tween20 (PBS-T; Appendix A). Diluted samples were snap frozen on dry ice 
and stored in a -20 °C freezer. 
 
3.3.3.2 LH pulse measurement 
In experiment B, for both male and female mice, repetitive tail-tip blood samples were 
collected between 0930-1230 h. To measure consecutive changes in LH concentration 
from pulses, a blood sample was taken every 6 mins over the course of 3 h. Here, 4 µl 
of blood was collected using a pipette tip and diluted in 54 µl of 0.05 % PBS-T 
(Appendix A). If necessary, further blood loss was stopped with gentle pressure 
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applied between fingertips. The diluted blood samples were snap frozen on dry ice 
and at the end of the experiment, they were stored in a -20 °C freezer. 
 
3.3.3.3 Corticosterone measurement 
Circulating corticosterone was measured in habituated female and male mice prior to 
and post s.c. corticosterone implant administration in Experiment A and B. Blood was 
collected in 70 µl heparin coated capillary tubes. Mouse tail was massaged, and the 
drop of blood on the tail tip was collected via capillary action until a quarter of the 
tube was filled. These capillaries were immediately placed on ice. They were then 
centrifuged at 5000 x g for 15 mins to separate the blood cells from the plasma. The 
resulting plasma was immediately frozen and stored at -20°C. 
 
3.3.4 Drug treatment 
3.3.4.1 CNO injections 
The pharmacologically inert drug, CNO (Advanced Molecular Technologies, 
#AMTA056-C016) was given at a dose of 2 mg/kg s.c. in order to activate hM4Di and 
hM3Dq receptors to excite or inhibit the RFRP neurons. A stock solution was prepared 
by dissolving 1.5 mg of CNO in 75 µl of dimethyl sulfoxide and then this was diluted 
with 15 ml of sterile physiological saline to achieve a 1 mg/ml solution. The 1 ml 
aliquots of 1 mg/ml solution were wrapped in foil and could be stored in a -20 °C 
freezer for up to 3 weeks. On the day of injection CNO solution was thawed and 
brought to room temperature before injecting. 
 
3.3.4.2 Corticosterone injections 
For investigating the effect of glucocorticoids on the preovulatory LH surge in 
Experiment A, corticosterone was acutely elevated on the day of the LH surge using 
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1 mg/kg s.c. corticosterone injections. Corticosterone (Sigma, #SC-300391A) (3 mg) 
was dissolved in 100 µl ethanol which was then diluted to 0.1 mg/ml in saline to form 
1 mg/kg of injectable corticosterone.  
 
3.3.4.3 Corticosterone implant preparation  
These implants were based on those previously reported by Luo et al. (2016). 
Corticosterone was coated on the outside of the silicone tube. The silicone rubber 
tubing with 1.02 mm inner diameter and 2.16 mm outer diameter (Silastic, #508-005) 
were cut in 50 mm sections. The 85:15 % of corticosterone and cholesterol mixture was 
prepared by adding 500 mg of corticosterone (Santa Cruz Biotechnology, #SC-
300391A) to 88 mg of cholesterol (Thermo Fisher Scientific, #55662) in a beaker. The 
beaker was placed on a hot plate and the mixture was melted at 250 °C for 5 mins. 
Following this, 50 mm silicone tube sections were dropped inside the beaker to fill the 
tube with the corticosterone mixture. The tubes were removed, and once the 
corticosterone filling had solidified, these tubes were submerged again in the mixture 
to form an even coat of corticosterone around the whole outer surface area of the tube. 
These implants were removed from the beaker and left to solidify on aluminum foil 
for 5 mins. The final product was an implant consisting of 95-120 mg corticosterone. 
These corticosterone implants were stored at room temperature covered in aluminum 
foil to protect from light, until use. 
 
3.3.4.4 Oestradiol implant preparation  
Capsules with 0.65 µg 17 b-oestradiol (Sigma, #E8875) were prepared as per the 
methodology described in Christian et al. (2005) and Luo et al. (2016). The outer 
structure of the implant was made using 18 mm sections of silicone rubber laboratory 
tube with a 1.02 mm inner diameter and 2.16 mm outer diameter (Silastic, #508-005). 
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One end of the tube was sealed by applying 2 mm of clear neutral silicone sealant 
(Dow Corning). A stock solution of 50 mg/ml 17 b-oestradiol was prepared in ethanol 
and was then mixed with sesame oil to get a final concentration of 30 µg/ml. Using a 
syringe with blunt 18 G needle, 30 µg/ml 17 b-oestradiol was filled in 13 mm of the 
capsule thus resulting in ~0.65 µg of b-oestradiol in each capsule. The open end of the 
tube was sealed with silicone adhesive. The capsules were stored covered in 
aluminum foil to prevent exposure to light and stored in a fridge at 4°C. 
 
3.3.5 Surgical manipulations 
Animals were first anesthetised with 2.5% isoflurane in 0.8 L/min oxygen. Standard 
aseptic techniques were used during the operation and hibitane solution (5 % 
chlorhexidine and 4 % isopropyl alcohol, Sumitomo Pharmaceuticals C. Ltd.) used for 
cleaning the skin shaved around the operation site. To prevent drying of the eye and 
subsequent retinal damage during the course of the surgery, Poly-Visc lubricating eye 
ointment (Alcon) was applied. As a long-lasting analgesic, 5 mg/kg s.c. caprofen 
(Carprieve, Provet) was delivered prior to operation. Mice were monitored for 3 to 5 
days post-surgery, as per the timeline specified in Experiment A and B. Further pain 
relief was given as required based on the animal’s appearance and body weight 
during the monitoring period. 
 
3.3.5.1 Ovariectomy in female mice 
For female mice in experiment A, endogenous oestradiol secretion was erased by 
subjecting these animals to bilateral ovariectomy (OVX). Animals were anesthetised. 
At the absence of pedal withdrawal reflex, they were given pain relief medication and 
prepared for aseptic surgery as described above. A 1.5 cm midline incision was made 
on the skin dorsal surface caudal to the rib cage. The abdominal cavity was exposed 
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by a second incision of 0.5 cm made on each side of the abdominal wall at 1.5 cm 
lateral to the spine. The ovaries were located, exteriorised, clamped with the hemostat 
and removed from the uterus. The abdominal cavity was closed by using 4.0 Softsilk 
sutures (Covidien, GS-831) on the muscle wall incisions. Wound clips (MikRon 
Precision Inc, autoclips) were used to close off the skin incision. 
 
3.3.5.2 Steroid implant insertion 
On the dorsal surface, skin was shaved, and a midline incision was made to create a 2 
cm deep s.c.  pocket extending rostrally by blunt dissection. The implants were placed 
in the s.c.  pocket, and the incision was closed off with the wound clips (MikRon 
Precision Inc, autoclips). In Experiment A, implants were placed immediately after 
ovariectomy by forming the s.c.  pocket prior to stapling the skin incision (Figure 3.5 
A). Here, to test the effect of chronic stress steroids on the LH surge, oestradiol and 
corticosterone implants were placed side by side laterally in the s.c.  pocket, whereas 
only the oestradiol implant was inserted in the control group. As a negative control 
for the oestradiol positive feedback induced LH surge, a group of OVX females 
without estradiol implants were also included in the study. In experiment B which 
only required corticosterone treatment, implants were placed on the afternoon of 







Figure 3.5: In-house steroid implants. A. Oestradiol implant with 0.65 µg 17 b-oestradiol 
filled inside the silastic tube. B. Corticosterone implant with ~100 mg of corticosterone and 
cholesterol coated on the external surface of the silastic tube. Scale bar = 1 cm.  
 
3.3.6 Hormone measurement 
3.3.6.1 LH enzyme-linked immunosorbent assay (ELISA) 
Whole blood LH concentration was measured using in-house ELISA first described 
by Steyn et al. (2013). On day one, the 96 well plates (Corning 96 Well Cleat Flat 
Bottom Polystyrene High Bind Microplate, #9018) were coated with LH monoclonal 
capture primary antibody (bovine LHb 518B7 monoclonal antibody obtained from 
Lillian E Sibley, University of California, Davis). For this, 50 µl of the 1:1000 capture 
primary antibody diluted in Phosphate buffered saline (PBS) was added to each well. 
The plate was placed in a humidified chamber and left overnight at 4 °C on an orbital 
mixing plate. The next day, capture antibody was decanted and 200 µl of blocking 
buffer (5% skim milk powder-PBS-Tween; Appendix A) was added to each well. This 
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was incubated for 2 h at room temperature inside the humidified chamber and on an 
orbital shaker; all subsequent incubations were done under these conditions.  
 
Blocking buffer was decanted and each well was washed three times with 200 µl 0.05% 
PBS-T (Appendix 1). Then, 50 µl of standards, a medium LH quality control sample 
(2-2.5 ng/ml), a low LH quality control sample (0.5-1 ng/ml) and PBS as negative 
control were loaded in the appropriate wells in duplicate. The LH surge blood 
samples were loaded in duplicate whereas the LH pulse samples were run in unicate, 
and the plate was incubated for 2 h. The wells were washed again with 200 µl of 0.05% 
PBS-T, repeated three times. Each well was then incubated in 50 µl of 1:1000 rabbit 
polyclonal LH antibody AFP240580Rb (AF Parlow mouse RIA kit, National Hormone 
Pituitary Programme) diluted in blocking buffer and the plate was incubated for 90 
mins. The plate was washed again and 50 µl of 1:1000 conjugated secondary antibody, 
polyclonal goat anti-rabbit IgG/HRP antibody (DAKO Cytomation polyclonal goat 
anti-rabbit IgG/HRP, #P0448) diluted in 2.5% skim milk powder-PBS-T was added to 
each well. This was incubated for 30 mins. 
 
The plate was washed again and 100 µl of o-phenylenediamine dihydrochloride 
(OPD; Sigma, #612146008) solution created from 1 OPD tablet dissolved in 50 ml of 
citrate buffer (Appendix 1) and 6 µl of 30% H2O2, was added to each well. The OPD 
reaction was light sensitive and hence the plates were covered with aluminum foil for 
this incubation. After 30 mins the OPD reaction was stopped by adding 50 µl of 3M 
HCL to each well and the plate was read at 490 nm using a standard absorbance plate 
reader. Sample values were corrected for dilution in PBS at the time of calculation. 
The sensitivity of the assay (95% confidence interval at 0 ng/ml on the standard curve) 
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was 0.1 ng/ml and the inter-assay coefficient of variation calculated across 28 plates 
was 2.25 %. 
 
3.3.6.2 Corticosterone ELISA 
Circulating corticosterone concentration was quantified via DetectX ELISA kit (Arbor 
Assays, Ann Arbor, MI, USA Cat No. K014-H5). The following steps were carried out 
as per the manufacturer’s protocol. The whole blood samples for Experiment Ai and 
plasma samples collected in section 3.6.3 for all other experiments (Aii, B1 and B2) 
were treated with dissociation buffer at the ratio of 1:1 and then diluted to the 
concentration of 1:100 in assay buffer. In a 96 well plate coated with donkey anti-sheep 
IgG, 50 µl of sample or standard was pipetted into each well. This was followed by 
addition of 25 µl DetectX corticosterone conjugate into each well and then adding 25 
µl of DetectX corticosterone antibody. All samples and standards were run in 
duplicates. As quality controls, two negative controls were included in each plate: 
duplicate wells of 50 µl of assay buffer instead of sample to test maximum binding at 
zero standard, and non-specific binding was tested by simply omitting the 
corticosterone antibody. Additionally, duplicates of known ~200 ng/ml 
corticosterone samples were included in each plate to assess inter-assay variability. 
 
Following sample loading, the plate was sealed, and adequate mixing of the reagents 
were ensured by gently taping the sides of the plate and incubating it on an orbital 
shaker for 1 h at room temperature. Plate wells were than washed with 300 µl of wash 
buffer, repeated 4 times. 100 µl of the TMB substrate was added into each well and the 
plate was again incubated for 30 mins at room temperature. The reaction was ceased 
by adding 50 µl of stop solution per well. Optical density generated by each sample 
was read at 450 nm in standard absorbance plate reader and corticosterone sample 
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concentrations were corrected for dilution at the time of the calculation. Assay 
sensitivity was 23.2 ng/ml and inter-assay coefficient of variation calculated across 10 
plates was 4.32 %. 
 
3.3.7 Immunohistochemistry 
3.3.7.1 Perfusion, fixation and sectioning 
Mice were perfused and their brains were harvested to measure difference in RFRP 
activity between control and DREADD activated mice. To verify upregulation of 
RFRP activity in corticosterone treated controls for Experiment B1 mice, brains of a 
separate cohort, corticosterone untreated (no implant) mice were also perfused. In 
order to activate RFRP excitatory and inhibitory DREADDs, all mice were 
administered with s.c. 2 mg/kg CNO 0.5 h prior to perfusion. Mice were then 
anesthetised with 240 mg/kg sodium pentobarbital (Pentobarb 300, Provert NZ Pty 
Ltd.) intraperitoneal administration. Once withdrawal reflex was absent, a mid-line 
incision was made through the upper abdomen to expose the heart. The right atrium 
was punctured and 20 ml of fixative, 4% paraformaldehyde (Appendix A) in 0.1 M 
phosphate buffer, pH 7.3 was injected into the left ventricle via a 21 G needle. Perfused 
brain was extracted and post-fixed overnight in the same fixative and then submerged 
into 30 % sucrose in 0.1 M PBS (Appendix A). The following day when brains had 
sunk in the sucrose solution, the brain stem was sliced off using a scalpel to form a flat 
base and the brains were placed on the stage of the sliding microtome. They were 
frozen to -18 °C and 3 series of 35 µm thick coronal sections were cut. Sliced sections 
were immediately transferred into well plates containing cryoprotectant and were 




After testing pCreb and cFos (Appendix 2C), expression of Fos-related antigen (FRA, 
which also labels cFos) was used as the neuronal activity marker. Here, FRA was 
colocalised with RFRP-3 using chromogenic dual label immunohistochemical staining 
to quantify RFRP neuronal activity between control and DREADD activated groups. 
Brain sections were first washed 3 times for 5 mins each in TBS-TX-bovine serum 
albumin (TBS-TX-BSA; Appendix A) and then incubated for 30 mins in 1 % hydrogen 
peroxide (H2O2) to quench endogenous peroxidase activity. Tissue sections were again 
washed 3 times for 5 mins each in TBS-TX-BSA. 
 
To label for RFRP neurons, sections were incubated for 48 h at 4 °C on an orbital 
mixing plate in 1 ml of 1:5000 rabbit anti-RFRP-3 (PAC123a, RRID:AB_2617160, from 
G Bentley, University of California Berkeley) diluted in TBS-TX-BSA containing 2% 
normal goat serum (same species as secondary antibody host). This was followed by 
the TBS-TX-BSA wash steps and then an incubation in 1:1000 biotinylated goat anti-
rabbit secondary antibody (Vector Laboratories) for 1 h on an orbital mixing plate at 
room temperature. The TBS-TX-BSA wash steps were carried out again and tissues 
were then incubated in Vector Elite avidin-biotin complex (ABC) solution (Vector 
Laboratories) for 1 h. Sections were washed again 3 times for 5 mins each in TBS-TX-
BSA before incubation in 0.5 % diaminobenzidine (Appendix A) and hydrogen 
peroxide solution (Sigma-Aldrich) for 5-7 mins until a light brown stain was visible. 
Sections were then washed 5 times for 5 mins each in TBS-TX-BSA and stored in TBS-
TX-BSA overnight on the orbital mixing plate at 4 °C. 
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Prior to co-labelling RFRP-3 stained sections with FRA, tissues were again incubated 
in 1% hydrogen peroxide for 30 mins. This was followed by the 3 times wash in TBS-
TX-BSA. Sections were then incubated in 1:2000 rabbit anti-FRA (Santa Cruz 
Biotechnology K-25; RRID: AB_2231996) diluted in TBS-TX-BSA containing 2% 
normal goat serum for 48 h at 4°C on the orbital mixing plate. Sections were washed 
again for 5 mins with TBS-TX-BSA and this was repeated 3 times. The FRA labelling 
was then directly revealed using horseradish peroxidase-conjugated goat anti-rabbit 
IgG (1:500; Dako Corporation, #P0448) and nickel-enhanced diaminobenzidine and 
hydrogen peroxide solution until a blue–black nuclear staining was observed. Lastly, 
sections were washed gain with TBS-TX-BSA 5 times for 5 mins each.   
 
A negative control was included in this dual label immunohistochemical staining 
where primary antibodies were omitted, and tissues were instead incubated in TBS-
TX-BSA containing 2% normal goat serum. In these sections, a non-specific staining 
by the secondary antibodies was not observed.  
 
3.3.7.3 Mounting tissues post immunohistochemical staining 
Sections were mounted onto gelatin-coated slides and were air-dried overnight.  
Sections were then dehydrated through a graduated series of alcohol (50%, 70%, 95% 
and 100%) and rinsed twice in xylene for 10 mins each before coverslipping with DPX 
mounting medium. All hypothalamic RFRP soma from at least 4 sections per animal 
were examined for FRA colocalisation at 200x magnification using light microscope 
(Olympus BX45).  
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3.3.8 Data analysis 
3.3.8.1 LH secretion 
To be counted as a LH surge, the animal had to exhibit 10-fold increase in basal LH 
concentration in the samples collected before lights out. For this the 1100 h sample 
was used as the measure of basal LH concentration and was compared to the highest 
LH concentration observed between samples collected at 1800, 1830 or 1900 h. 
 
The following criteria was used for LH pulse identification: a pulse must have at least 
two data points higher than a preceding or a following nadir and must have a peak of 
at least 1.5 x times higher than the preceding a preceding or a following nadir. The 
pulse amplitude had to be higher than 0.2 ng/ml (i.e. two times the assay sensitivity).  
 
3.3.8.2 Statistical analysis 
All data are presented as mean ± the standard error of the mean (SEM) and a P value 
less than 0.05 (P<0.05) was considered to be a significant result. Statistical analyses 
were performed by using unpaired Student’s t tests to compare single time point 
differences between two groups and one-way ANOVA to compare single time point 
differences among more than two groups. Ordinary two-way ANOVA was used 
whereby CNO, corticosterone and/or genotype were the factors for comparison. A 
two-way repeated measure (RM) ANOVA was used when comparing data from the 
same animal prior to and with corticosterone treatment, or between saline and CNO 
treatment. If a significant main effect or interaction was found, Holm-Sidak multiple 
comparisons post hoc testing was used to identify where the difference(s) occurred. 






The results are divided into two main sections. First shown are Experiment A results 
for an attempt to establish a model for glucocorticoid-induced suppression of the 
preovulatory LH surge. The second section includes results from Experiment B for 
glucocorticoid-induced suppression of pulsatile LH secretion, as modulated by RFRP 
neuronal activity. 
 
4.1 Experiment A: LH surge model 
4.1.1 Naturally cycling mice: LH concentration 
In order to measure the effects of silencing RFRP neurons on glucocorticoid-induced 
preovulatory LH surge suppression, a model for corticosterone treatment-induced 
surge suppression needed to be established. The first attempt at measuring the effect 
of high corticosterone on the preovulatory LH surge was assessed in naturally cycling 
control female mice. Two control groups, saline injected mice and non-injected mice 
(received no treatment) along with corticosterone injected mice were included in this 
experiment. A minimum of a 10-fold increase in circulating LH concentration in 
comparison to the basal 1100 h sample for each animal was classified as a surge. 
Among the three groups, only non-injected mice exhibited an LH surge, with a mean 
peak LH concentration of 26.5±7.76 ng/ml (P=0.0001 vs 1100 h values; Figure 4.1 B). 
No significant increase in LH concentration was observed between 1800 -1900h for the 
saline injected or corticosterone injected female mice (Figure 4.1 A). Similarly, the 
average area under the LH secretion curve for saline treated mice (5.1±0.25) was 
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similar to that of corticosterone treated mice (2.2±0.98), and both were significantly 
lower in comparison to the non-injected mice (30.7±7.22, P<0.01) (Figure. 4.1). 
                                 A. 





Figure 4.1 LH concentration in the proestrus phase of estrous cycle for naturally cycling 
control female mice. A.  LH profiles of animals in the non-injected (n=5), saline injected (n=5) 
and corticosterone injected (n=5) groups. Each data point represents mean± SEM LH 
concentration of each group at the graphed time on x-axis. Underline indicates the time of 
saline and corticosterone injection administration. B. Comparison of basal LH concentration 
measured at 1100 h with the highest observed concentration of LH between 1800 to 1900 h, 
labelled as surge. Basal and surge value for an individual animal is shown as a data point and 
the collective difference is analysed using repeated measures two-way ANOVA followed by 
Holm-Sidak’s multiple comparison test. C. Mean area under the curve (AUC) for each 
treatment group with each data point showing AUC obtained from the LH profile of an 
individual animal. Difference between groups analysed using one-way ANOVA and Tukey’s 
multiple comparison test. **P<0.01, ****P<0.0001, error bars represent ± SEM.  
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4.1.1.1 Naturally cycling mice: corticosterone treatment 
Leftover blood sample collected for LH measurement was used to substantiate the 
concentration of corticosterone circulating at each time point for mice post saline or 
corticosterone treatment. Contrary to the Detect X Corticosterone assay kit protocol, 
these samples were unconventionally diluted with PBS-T. To confirm that the assay 
remained sensitive and robust under these conditions, a dilution curve was generated 
to measure the effect on assay sensitivity. The concentration of a 16 times serially 
diluted known high corticosterone blood sample was graphed, alongside the 
mathematically predicted concentration, against each dilution factor (1x, 2x, 4x, 8x, 
16x., Figure 4.2). Corticosterone concentration observed for dilution factors followed 
the same trend as the mathematically generated curve (Figure 4.2). A maximum 
deviation of 5.6 ng/ml was observed at 2x dilution and minimum deviation of 0.3 
ng/ml was seen in the 4x diluted sample (Figure 4.2). The mean deviation from all the 
dilution factors tested was 1.95 ng/ml in comparison to the theoretically calculated 
value. The lower sensitivity of the diluted blood sample was 8.1 ng/ml. These results 






Figure 4.2 Corticosterone ELISA sensitivity for measuring concentration in whole blood 
samples. A sample collected from a wild type female mouse post inducing 30 mins of restrain 
stress, was serially diluted in steroid stripped blood. Each sample was then diluted with PBS-
T and assayed as per the Detect X Corticosterone kit protocol. The solid black line shows the 
concentration curve generated with optical density measured at 450nm. Concentration at each 
dilution factor was measured in duplicate and their average is shown as a black circle. The 
dotted line shows the mathematically generated curve from halving the initial concentration 
at each dilution factor 
 
For the non-injected mice, blood corticosterone concentration remained low (40-90 
ng/ml) during 1100-1900 h (Figure 4.3 A). The corticosterone concentration was 
elevated post-treatment from 1100 h in the corticosterone injected mice, but also in the 
saline injected mice. For both treatment groups, the mean circulating corticosterone 
concentration on the day of saline injections (197.6±14.97 ng/ml) and corticosterone 
injection  (235.0±66.12 ng/ml) were not significantly different from each other, while 
both values were higher than the 50.5±6.23 ng/ml mean reported for the non-injected 
mice (P<0.05; Figure 4.3 B). The increase in circulating corticosterone for the saline 
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treated group revealed a major confounding effect that the process of handling and 
injection had on the exogenous corticosterone treatment, even though these mice had 
been habituated to the process over several days. Therefore, use of multiple injections 









Figure 4.3. Whole blood circulating corticosterone concentration in naturally cycling 
control female mice after saline and corticosterone treatment. A. Corticosterone 
concentration profile for non-injected(n=5), saline injected (n=5) and corticosterone injected 
(n=5) female mice. Each data point represents a group mean±SEM concentration at the 
graphed time on the x-axis. B. Bar graph of mean± SEM corticosterone concentration across 
treatment groups. Each data point is an average corticosterone concentration for an individual 
animal calculated from the five samples (excluding the 1100 h pre-treatment sample) collected 
during the light-phase. One-way ANOVA followed by Holm-Sidak’s multiple comparison 
test. *P<0.05, error bars represent ± SEM.  
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4.1.1.2 Ovariectomised mice treated with chronic corticosterone implants 
Due to the difficulties encountered with repeated corticosterone injections, chronic s.c.  
corticosterone implants were used for a more efficient method of corticosterone 
delivery. This approach is also more suited to modelling long-term stress and is 
therefore relevant to emulating the endocrine stress response associated with 
persistent infertility. Chronic corticosterone release from the implant is known to 
disturb oestrous cyclicity and decrease the occurrence of proestrus (Luo et al., 2016). 
Hence, control female mice were ovariectomised (OVX) and a pilot experiment was 
designed to test corticosterone’s effect on the estradiol implant induced LH surge. The 
rationale for switching to an OVX, exogenous oestrogen surge model was that it was 
hoped to be less prone to disruption by handling stress and logistically easier due to 
being able to schedule an entire experiment on the same day. This experiment 
included three sets of OVX mice: 1) no implant mice as steroid treatment control, 2) 
oestradiol implant for surge induction 3) oestradiol and corticosterone implants for 
glucocorticoid induced LH surge suppression. Hormone implants were placed 
subcutaneously at the time of ovariectomy. 
 
4.1.1.2.1 Body weight 
No statistically significant difference in mean body weight was observed before and 
3 days after ovariectomy for mice with no implants or consisting of only oestradiol 
implant (Figure 4.4). However, a significant decrease of 1.2± 0.22 g was observed in 





Figure 4.4 Mean body weight for 3 days before and after ovariectomy surgery with hormone 
treatment. Each data point represents mean body weight for an individual animal. Two-way 




4.1.1.2.2 Female vaginal cytology 
Vaginal cytology was quantified before and after ovariectomy to confirm the 
functional effects of ovary removal and oestradiol replacement (Appendix 2E). OVX 
mice with no implant had a mean of 69.7±5.49 % increase in the occurrence of 
dioestrus-like smears (Figure 4.5). On the other hand, OVX mice with oestradiol only 
or oestradiol + corticosterone implants showed a preponderance of oestrus-like 
smears. Mean time in oestrus was increased by 71.4±3.12 % and 67.6±3.69 % for 
oestradiol only and the oestradiol + corticosterone implant group, respectively (Figure 
4.5). There was no occurrence of proestrus like smears post ovariectomy in mice of 








Figure 4.5. Vaginal cytology before and after ovariectomy. A. Representative oestrous cycle 
and post-OVX cytology profiles determined by vaginal cytology for OVX+oestradiol and 
OVX+oestradiol+corticosterone treatment group. P, E, M and D stand for proestrus, oestrus, 
metoestrus and dioestrus-like smears respectively. B. Change in percentage of time spent in 
each phase of oestrous cycle calculated by measuring occurrence of cycle phase in 12 days 
before OVX and 3 days after. Positive values on y-axis represents increase and negative 




4.1.1.2.3 Corticosterone concentration 
Blood samples were collected for corticosterone measurements at 19.00 h (i.e. post LH 
blood sampling). The corticosterone concentration was lowest in the OVX no implant 
mice (12.5± 2.39 ng/ml) and oestradiol implant only mice (18.1± 2.90 ng/ml). As 
expected, the OVX mice with the oestradiol+corticosterone implant had a significantly 
higher mean circulating corticosterone concentration of 205.4± 77.70 ng/ml but also 
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had more individual variability compared to the other two groups (P<0.05; Figure 
4.6).  
 
Figure 4.6. Circulating corticosterone concentration for OVX no implant (n=5), oestradiol 
(n=7) and oestradiol+corticosterone (n=7) groups. Bar graph for group mean±SEM 
corticosterone concentration measured in plasma on the third day after implant placement. 
Data points represent corticosterone concentration for an individual animal.  One-way 
ANOVA with Tukey’s multiple comparison test showed a significant increase in circulating 
corticosterone with s.c. corticosterone implant treatment (*P<0.05).  
 
 
4.1.1.2.4 LH secretion 
Oestrogen-induced LH surges were not observed for mice in either of the oestradiol 
implanted treatment groups. Unexpectedly, in Figure 4.7A, an LH surge like peak of 
mean 5.6±0.55 ng/ml was seen between 1800-1900 h for no implant OVX mice in 
comparison to their 1.9±0.26 ng/ml mean concentration at 1100 h (P<0.0001). 
However, the LH profile of the individual no implant mice exhibited constant 
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fluctuation of LH concentration during the light phase and unlike a surge, the peak in 
LH concentration were outside of the 1800-1900 h time period in 3 out of 5 animals 
(Appendix 2F). This was also reflected in the high basal LH concentrations in this 
group (Figure 4.7 B). The area under the LH secretion curve (AUC) was analysed for 
each group. There was an unanticipated statistically significant higher mean AUC 
observed for no implant mice (16.6±2.46) in comparison to the oestradiol conditioned 
mice (P<0.0001). No significant difference was observed between mean AUC of mice 
with oestradiol implant (1.4±0.55) and mice treated with both oestradiol and 
corticosterone implants (1.9±0.53; Figure 4.7 C). 
 
Due to the ineffectiveness in developing a robust preovulatory LH surge assessment 
paradigm and an adequate model for high circulating glucocorticoid mediated 
inhibition of the LH surge, the surge experiments were terminated. Experiment B 
focused instead on the tonic LH pulses that regulate the HPG axis at times outside the 
preovulatory surge. Since this type of regulation occurs in both sexes, the experiments 
were conducted in males and females. 
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   C.  
 
 
Figure 4.7 Oestradiol implants were insufficient in inducing LH surge in ovariectomised 
mice. A. LH profiles three days after treatment of OVX mice with no implant (n=5), oestradiol 
implant (n=7) and oestradiol+corticosterone implant (n=7). Each data point represents the 
mean±SEM LH concentration of the group for the graphed time on x-axis. B. Basal sample 
gathered at 1100 h compared with the highest concentration observed between 1800-1900 h 
labelled as surge. Data analysed using repeated measured two-way ANOVA followed by the 
Holm-Sidak’s multiple comparison test. C. Mean area under the curve (AUC) for each 
treatment group presented with each data point showing AUC of an individual animal of the 
group. Difference between groups analysed using one-way ANOVA followed by Tukey’s 
multiple comparison test. ****P<0.0001, error bar represent ± SEM. 
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4.2  Experiment B: RFRP neuronal requirement and sufficiency for 
glucocorticoid-induced suppression of pulsatile LH secretion 
This section encompasses male and female data from acutely silenced RFRP neurons 
in RFRP-hM4Di mice, followed by the results of acute hyperactivation of RFRP 
neurons on pulsatile LH secretion for RFRP-hM3Dq mice. In the absence of CNO, 
normal pubertal development, reproductive cycles and fecundity of the RFRP-hM4Di 
and RFRP-hM3Dq in comparison to the DREADD non-expressing littermate control 
mice has already been established in the Anderson lab by India Sawyer (2017). 
 
4.2.1  B1. Are RFRP neurons required for glucocorticoid-induced neuroendocrine 
suppression of pulsatile LH secretion? 
4.2.1.1 Silencing RFRP neuronal activity 
Double label immunohistochemistry for RFRP-3 and FRA were used to confirm that 
an injection of CNO reduced the activity of RFRP neurons only in RFRP-hM4Di mice. 
Results presented here are from brain tissue collected with CNO + chronic s.c. 
corticosterone implant treated control and RFRP-hM4Di mice. According to previous 
publications elevated circulating corticosterone levels should upregulate 
hypothalamic RFRP activity (Son et al., 2014). Therefore, hypothalamic brain sections 
of the corticosterone untreated (no implant) control male and female mice were also 
analysed to assess the effect of the corticosterone implant on RFRP neuronal activity.  
 
Males 
Corticosterone mediated upregulation of the RFRP activity in the DMH is seen in the 
CNO + corticosterone treated control males which exhibited significantly higher mean 
coexpression of FRA and RFRP-3 (61.3±6.82 %) in comparison to the no implant males 
(39.1±3.71 ng/ml; t(17)=3.300, P=0.0084). The effect of CNO was seen in the 
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corticosterone treated RFRP-hM4Di mice with a strikingly low mean of 23.6±1.59 % 
RFRP and FRA colocalisation. This mean RFRP activity measured for the RFRP-
hM4Di males was significantly lower than that of the CNO + corticosterone treated 
control males (t(17)=5.838, P<0.0001) and furthermore, also lower than the RFRP 
activity observed in the no implant males (t(17)=2.309, P=0.034); therefore showing 
evidence of widespread neuronal silencing (Figure 4.8 A). 
 
Females 
Similar to the male data, the CNO + corticosterone treated control females had the 
highest RFRP and FRA colocalisation mean of 62.4±4.42% which was significantly 
higher than the 41.8±5.23% mean RFRP activity observed in the no implant group 
(t(18)=2.943, P=0.0173; Figure 4.8 B). The effect of CNO on silencing RFRP neurons 
was apparent in the corticosterone treated RFRP-hM4Di female that had 35.0±4.68 % 
active RFRP colocalisation which is significantly lower than the corticosterone treated 
control mice (t(18)=4.197, P<0.002; Figure 4.8 B). No statistical significance was 
















 Figure 4.8 RFRP-silencing reduces corticosterone-induced RFRP neuronal activity. A. 
Percentage of FRA and RFRP-3 colocalisation in male control (n=7), RFRP-hM4Di (n=8) after 
4 days of corticosterone treatment and for a separate cohort without corticosterone treatment, 
the no implant mice (n=6). B. Colocalisation for the female control (n=8), RFRP-hM4Di (n=9) 
after 4-5 days of corticosterone treatment and for the no implant mice (n=4). Brain sections 
with less than 4 neurons were excluded from the analysis. Approximately 4-5 brain sections 
were counted for each animal with the average percentage of colocalisation across brain 
sections from each animal graphed as an individual data point. Representative example are 
as follow: C. Negative control i.e. removal of primary FRA and RFRP antibody from the dual 
label immunohistochemical stain. D. A no implant mouse RFRP-3 and FRA labelled brain 
section (both C and D belong to the same animal). E. Control mice with a magnified active 
RFRP neuron consisting a dark FRA stained nucleus. F. RFRP-hM4Di mice with the magnified 
inactive RFRP neurons. Data represents mean±SEM. One-way ANOVA and Holm-Sidak’s 
multiple comparison tests. *P<0.05, **P<0.01, ****P<0.0001. Scale bar = 200µm. 
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4.2.1.2 Chronic stress model 
4.2.1.2.1 Circulating corticosterone concentrations 
All mice were treated with s.c. corticosterone implant to emulate the chronic 
endocrine stress response. The trend of elevated circulating corticosterone levels, as 
profiled from blood samples collected at 9.00 h every day for each animal post implant 
placement, is shown in Figure 4.9 A.  Mice of all four groups, control (male and female) 
and RFRP-hM4Di (male and female) exhibited extremely high circulating 
corticosterone concentration of more than 2000 ng/ml on the day 2 of corticosterone 
implantation. The circulating corticosterone concentration declined on the following 
days of the implant and more constant release was noted on day 4 and 5 (Figure 4.9 
A).  
 
The mean basal corticosterone concentration for control male, RFRP-hM4Di male, 
control female, RFRP-hM4Di female mice were 64.0±16.36, 66.7±16.62, 94.8±19.02 and 
65.9±10.57 ng/ml respectively. Circulating corticosterone concentration on the last 
day of implant was noted to be significantly higher than pre-implant values for all 
groups (P<0.00002): control male (628.9±71.93 ng/ml), RFRP-hM4Di male 
(591.9±57.67 ng/ml), control female (467.4±40.02 ng/ml) and RFRP-hM4Di female 
(432.9±43.34 ng/ml) (Figure 4.9 B-C). These values are at the higher end of the range 














Figure 4.9 Subcutaneous corticosterone implant induced elevation in circulating 
corticosterone concentration. A. Corticosterone concentration profile for male and female 
treatment groups. Basal corticosterone measured at 0900 h on day 1 prior to implant 
administration followed by concentrations with implant, days 2 to 5. B. Male (control n= 8, 
RFRP-hM4Di n=9) and C.  Female (control n= 8, RFRP-hM4Di n=9) basal concentration from 
day 1 in black compared with concentration on the day of second LH pulse bleed (day 4 or 5) 
in red bars. Data represents mean± SEM. Two-way repeated measures ANOVA followed by 
Holm-Sidak’s multiple comparisons test (****P<0.0001). 
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4.2.1.2.2 Body weight 
Stress-like glucocorticoid levels are known to have lipogenic effect and here, a 
significant increase in mean body weight was observed for both male and female mice 
with corticosterone treatment (Figure 4.10). In response to at least 4 days of 
corticosterone treatment, a mean increase of 3.5±0.59 g, 2.6±0.62 g, 2.4±2.41 g and 
4.1±0.56 g was observed for control male, RFRP-hM4Di male, control female and 








Figure 4.10 Effect of corticosterone implant on body weight. A. Body weight profile in grams 
for male (control n=7, RFRP-hM4Di n=8) and female (control n=8, RFRP-hM4Di n=9) mice 
prior to implant administration (day 1 to 6) and in the presence of subcutaneous corticosterone 
implant (day 7 to 10). B. Each data point represents average body weight of an individual 
animal before implant compared with average weight in the presence of corticosterone 





4.2.1.2.3 Corticosterone treatment and oestrous cycle  
Chronic stress is known to disrupt reproductive cyclicity in females (Luo et al., 2016). 
Here, female control and RFRP-hM4Di mice followed a regular 5-6 day cycles prior to 
glucocorticoid treatment. The limited data for 4-5 days of glucocorticoid treatment in 
comparison to the 14 day period prior to treatment for each animal was mitigated by 
pooling the data for the control and RFRP-hM4Di groups to increase ‘n value’. There 
was significant reduction in the occurrence of proestrus (16.29±2.94 % basal and  
2.94±2.01 % with implant; (t(16)=6.111, P<0.001) and oestrus (35.75±1.74 basal and  
25.0±4.29 % with implant; t(16)=2.250, P<0.05) coinciding with corticosterone implant 
administration (Figure 4.11). Time spent in metoestrus (23.08±0.93 basal and 
32.35±5.15 % with implant; t(16)=1.82, P=0.087) and dioestrus (24.89± 1.04% basal and 














Figure 4.11. Effect of subcutaneous corticosterone implant on oestrous cyclicity of female 
mice.  A. Representative profile of variation in oestrous cyclicity at basal condition (days 1 to 
13) and with corticosterone implant treatment (days 14 to 18). B. Average percentage of time 
spent in each phase of the oestrous cycle. Data for control and RFRP-hM4Di mice was pooled. 
Black bars represent collective mean± SEM at basal corticosterone concentration whereas red 
bars represent mean± SEM in the presence of corticosterone implant. Paired Student’s t-test, 
n=17. *P<0.05, ***P<0.001. 
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4.2.1.3 Effect of silencing RFRP neurons on glucocorticoid-induced suppression 
of pulsatile LH secretion. 
Chronic glucocorticoid treatment disrupts LH pulses in mice (Kreisman et al., 2019). 
It was hypothesised that if hypothalamic RFRP neurons are required for modulating 
glucocorticoid-induced LH suppression, silencing their cell signalling should, to some 
degree, restore LH pulsatility. To account for fluctuating baseline levels, all pulses 
with peaks below the 0.2 ng/ml threshold (2 x sensitivity of the assay) were excluded 
from the analysis.  
 
Males 
RFRP silencing had no effect on corticosterone-induced suppression of LH secretion 
in males. Both control and RFRP-hM4Di male mice exhibited a similar significance in 
suppression of mean circulating LH concentration with corticosterone treatment 
(controls: t(13)=2.176, P=0.049; RFRP-hM4Di; t(13)=2.541, P=0.049; Figure 4.12 A). The 
basal LH for control males 0.73±0.14 ng/ml was reduced to 0.37±0.06 ng/ml with 
corticosterone treatment and similarly circulating LH concentration for RFRP-hM4Di 
males reduced from 0.687±0.17 ng/ml to 0.25±0.06 ng/ml.  
 
Likewise, the suppressive effect of corticosterone was also observed on the LH pulse 
frequency for the controls (1.38±0.19 pulses/h basal, 0.92±0.06 pulses/h with 
corticosterone; t(13)=2.541, P=0.0486; Figure 4.12 B,D,E) and for the RFRP-hM4Di 
males (1.29±0.15 pulses/h basal; 0.86±0.12 pulses/h with corticosterone; t(13)=2.438, 
P=0.0305; Figure 4.12 B,F,G). However, a statistical significance was not achieved for 
changes in pulse amplitude with corticosterone treatment in either the control 
(2.01±0.58 ng/ml basal, 1.01±0.32 ng/ml with corticosterone; t(13)=1.640, P=1.250) or 
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the RFRP-hM4Di males (2.036±0.68 ng/ml basal, 0.52±0.12 ng/ml with corticosterone; 
t(13)=2.219, P=0.089) (Figure 4.12 C). 
 
Finally, there were no statistically significant differences before or after corticosterone 
treatment between control and RFRP-hM4Di males in either LH concentration, pulse 





Figure 4.12. RFRP neuronal silencing does not rescue corticosterone-induced suppression 
of LH secretion in males. A. LH concentration at basal endogenous corticosterone compared 
with 4-days of high corticosterone treatment for control and RFRP-hM4Di mice. Data points 
represent average of 30 LH samples for each animal collected between 0930-1230 h. B. LH 
pulse frequency under basal conditions compared with corticosterone treatment. C. LH pulse 
amplitude under basal condition compared with corticosterone treatment. Data points 
represent mean LH pulse amplitude observed for the individual animals in each group. Pulses 
without a preceding nadir were excluded from the analysis. Representative examples of LH 
profiles are as follow: D. Control male in basal condition E. Control male mice with 
corticosterone treatment F. RFRP-hM4Di male mice in basal condition G. RFRP-hM4Di male 
mice with corticosterone treatment. Black circles represent pulse peaks. All data (control n= 
7, RFRP-hM4Di n=8) represent mean± SEM and are analysed with two-way repeated 
measures ANOVA, followed by Holm-Sidak’s multiple comparisons test. *P<0.05  
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Females 
Looking at the LH data prior to and with corticosterone treatment for individual 
groups, control females as expected exhibited a significant corticosterone-induced 
suppression of the mean circulating LH concentration over a 3 h sampling period 
(1.1±0.21 ng ml basal, 0.39±0.17 ng/ml with corticosterone; t(15)=4.132, P=0.002). 
Similarly, a significant decrease in basal LH pulse frequency (1.54±0.15 pulses/h) was 
observed in the control group under corticosterone treatment (0.38±0.11 pulses/h) 
(t(15)=8.475, P<0.0001; Figure 4.13 B,D,E).  
 
In contrast to this, the RFRP silenced RFRP-hM4Di females strikingly did not exhibit 
reduction in either LH concentration (0.50±0.11 ng/ml basal, 0.52±0.139 ng/ml with 
corticosterone; t(15)=0.125, P=0.902; Figure 4.13 A) or LH pulse frequency (1.23±0.10 
pulses/h basal, 1.074±0.12 pulses/h with corticosterone; t(15)=1.648, P=0.120); Figure 
4.13 B,F,G). The magnitude of rescue in LH secretion was further analysed by 
contrasting LH pulse amplitude before and with glucocorticoid treatment. Again, the 
corticosterone treatment did not have a significant effect on the amplitude for RFRP-
hM4Di mice (0.9±0.21 ng/ml basal, 0.71±0.16 ng/ml with corticosterone; t(15)=0.280, 
P=0.780; Figure 4.13 C). As expected for the control female mice, corticosterone 
treatment indeed caused a significant reduction in the LH pulse amplitude (3.51±1.02 
ng/ml basal, 0.60±0.31 ng/ml with corticosterone; t(15)=3.52, P=0.006). 
 
When comparing the intergroup data, a lower basal mean LH concentration was 
observed for RFRP-hM4Di group in comparison to the controls (t(30)=2.650, P=0.025) 
but the mean basal LH pulse frequencies of the two groups were similar (t(30)=0.615, 
P=0.543; Figure 4.13 A, B). The effect of RFRP silencing is furthermore evident with 
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the mean LH pulse frequency under corticosterone treatment for the control group 





Figure 4.13 RFRP neuronal silencing prevents glucocorticoid-induced LH suppression in 
females. A. LH concentration at basal endogenous corticosterone compared with 4-5 days of 
high corticosterone treatment for dioestrus control and RFRP-hM4Di mice. Data points 
represent average of 30 LH samples for each animal collected between 0930-1230 h. B. LH 
pulse frequency under basal condition compared with corticosterone treatment. C. LH pulse 
amplitude under basal condition compared with corticosterone treatment. Data points 
represent mean LH pulse amplitude observed for the individual animals in each group. Pulses 
without a preceding nadir were excluded from the analysis. Two data points in the female 
basal control group were outside the range of the y axis. Representative examples of LH 
profiles are as follow: D. Control female in basal condition E. Control female mice with 
corticosterone treatment F. RFRP-hM4Di female mice in basal condition G. RFRP-hM4Di 
female mice with corticosterone treatment. Black circles represent pulse peaks. All data 
(control n= 8, RFRP-hM4Di n=9) represent mean± SEM and are analysed with two-way 
repeated measures ANOVA, followed by Holm-Sidak’s multiple comparisons test. *P<0.05, 
**P<0.01, ****P<0.0001. 
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4.2.2 B2.  Are actions of endogenous RFRP hyperactivity sufficient for 
neuroendocrine suppression of pulsatile LH secretion? 
4.2.2.1 Validating hyperactive RFRP neuronal signalling 
The inclusion criteria for calculating the percentage of active RFRP neurons were kept 
consistent with the RFRP neuron silencing experiment. All mice were given 2 mg/kg 
CNO prior to perfusion to activate excitatory DREADD receptors and double label 
immunohistochemistry for RFRP-3 and the activity marker FRA were used to confirm 
CNO mediated upregulation of RFRP neuronal activity in male and female mice. 
 
In both male and female mice, the RFRP-hM3Dq group exhibited a significantly 
greater percentage of RFRP and FRA colocalisation than the control group. Male 
control mice had a group mean of 30.6±2.46 % RFRP neuronal activity whereas 
70.7±4.15 % was measured in the RFRP-hM3Dq group (t(5)=7.528, P=0.0007; Figure 
4.13 A). On a similar spectrum, control females exhibited 36.0±1.12 % RFRP activity 
while a high activity of 77.1±3.77 % was observed for the female RFRP-hM3Dq group 










Figure 4.14 Upregulated RFRP neuronal activity with CNO treatment and hM3Dq 
expression. Percentage of FRA and RFRP-3 colocalisation in A. male (control n=3, RFRP-
hM3Dq n=5) and B. female (control n=2, RFRP-hM3Dq n=3) mice. Sections with less than 4 
neurons were excluded from the analysis and approximately 4-5 brain sections were counted 
for each animal with the average percentage of RFRP-3 and FRA colocalisation across brain 
sections from each animal graphed as an individual data point. C. Representative section for 
a control mouse with a magnified cluster of inactive RFRP neurons. D. Representative section 
from a RFRP-hM3Dq mouse with a magnified dark FRA stained nucleus (green arrow) 
surrounded by 2 FRA negative RFRP neurons (red arrows). All data presented are 
mean± SEM Unpaired Student’s t test (**P<0.01). Scale bar = 200 µm 
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4.2.2.2 Effect of hyperactivation of RFRP neurons on corticosterone secretion 
Since a functional link between i.c.v RFRP-3 administration and an increase in 
circulating glucocorticoid concentration has been previously demonstrated (Kim et 
al., 2015) the CNO-induced hyperactivation of RFRP neurons should have a positive 
influence on the HPA axis. Therefore, the biological effectiveness of RFRP activation 
by CNO was also tested by measuring the circulating corticosterone concentration 
along with the reproductive hormonal effects. As per Figure 3.3, circulating 
glucocorticoid corticosterone concentration was first measured in the blood sample 
collected 0.5 h after administering s.c. 2 mg/kg CNO and after the 3 h serial blood 
sampling for LH i.e. 3.5 h after the CNO injection. This experiment was repeated in 
the same animals with the CNO injections replaced by saline injections as an 




The control mice did not exhibit statistical significance in mean circulating 
corticosterone concentration at 0.5 h between saline (127.2±41.01 ng/ml) and CNO 
treatment (94.7±15.83 ng/ml; Figure 4.15 A). After LH blood sampling at 3.5 h, 
corticosterone with saline treatment increased to 270.4±53.1 ng/ml but this still 
remained statistically insignificant to the concentration post CNO treatment 
(180.8±37.49 ng/ml; t(6)=0.793, P=0.458; Figure 4.15 B, C).  
 
As expected for the excitatory DREADD expressing RFRP-hM3Dq mice, CNO 
administration induced a significant increase in circulating corticosterone 
concentration at both 0.5 h and 3.5 h in comparison to the saline treatment. The mean 
corticosterone concentration for RFRP-hM3Dq mice at 0.5 h after saline treatment was 
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96.4±26.23 ng/ml whereas a high of 913.8±90.51 ng/ml was observed after CNO 
administration (t(6)=12.460, P<0.0001; Figure 4.15 A). Similarly at 3.5 h, a high of 
710.1±98.77 ng/ml corticosterone in circulation was observed from CNO 
administration in comparison to the 227.6±35.66 ng/ml observed with saline 
treatment (t(6)=5.522, P=0.003; Figure 4.15 B).  
 
This biological effectiveness of CNO with respect to time was also assessed. The CNO 
induced increase in circulating corticosterone concentration in RFRP-hM3Dq mice at 
0.5 h reduced significantly at 3.5 h after treatment (t(6)=5.952, P=0.002; Figure 4.15 D). 
Nevertheless, as mentioned earlier, these concentrations were both significantly 
higher than the saline treatment in RFRP-hM3Dq mice but also than the CNO 
treatment in control mice (t(12)=0.336, P<0.0001). Through the positive feedback of 
RFRP neurons on the HPA axis, these results show that the upregulated hypothalamic 
RFRP activity was maintained throughout the 3 h LH sampling period to a 







Figure 4.15 Upregulation in RFRP neuronal signalling increases corticosterone secretion in 
males. Corticosterone concentration in control (n=3) and RFRP-hM3Dq (n=5) males after A. 
0.5 h and B. 3.5 h saline (blue) and CNO (yellow) administration. CNO administration 
significantly increased corticosterone secretion only in RFRP-hM3Dq mice at both time points. 
The biological effectiveness of CNO in relation to time was analysed with first placebo 
injection C. saline and then  D. CNO. All animals were subjected to 3 h of repeated blood 
sampling for LH between 0.5 and 3.5 h sample collection. Between 0.5 h and 3.5 h samples, a 
significant increase in corticosterone is seen in the repeatedly blood sampled, saline treated 
control and RFRP-hM3Dq mice. CNO did not affect corticosterone concentration in control 
mice at either time points. CNO induced increase in corticosterone secretion in RFRP-hM3Dq 
mice, although present at both 0.5 h and 3.5 h, deteriorated with time. Data represents mean 
mean± SEM and is analysed bytwo-way repeated measures ANOVA followed by Holm-







As expected for control mice, no significant effect of CNO treatment was observed on 
circulating corticosterone concentration with respect to saline treatment. This was 
observed for both samples collected at 0.5 h (22.9±8.39 ng/ml with saline and 
118.7±54.07 ng/ml with CNO; t(3)= 1.115, P=0.346; Figure 4.15 A) and 3.5 h (61.9±51.71 
ng/ml with saline and 200.4±52.09 ng/ml with CNO; t(3)=0.891, P=0.439; Figure 4.15 
B) after treatment. 
 
For RFRP-hM3Dq mice, similar to males, females also had an increase in 
corticosterone concentration following CNO treatment. However, the difference in 
corticosterone concentration between saline (41.0±16.04 ng/ml) and CNO (936.2 
±86.49) for RFRP-hM3Dq group was only significant after 0.5 h of treatment 
(t(3)=12.76, P=0.002; Figure 4.15 A). At 3.5 h, a high of 588.9±155.92 ng/ml 
corticosterone concentration was measured post CNO administration in contrast to 
95.9±19.65 ng/ml after saline administration, however statistical significance was not 
achieved likely due to a small sample size of the group (t(3)=3.886, P=0.0595; Figure 
4.15 B). 
 
Saline and CNO treatment effect over time on the circulating corticosterone 
concentration, did not significantly differ between 0.5 h and 3.5 h sample for either 











    D. 
 
 
Figure 4.16 Upregulation in RFRP neuronal signalling increases corticosterone secretion in 
females. Corticosterone concentration in control and RFRP-hM3Dq females after A. 0.5 h and 
B. 3.5 h of saline (blue) and CNO (yellow) administration. Increase in CNO induced 
corticosterone secretion in RFRP-hM3Dq is significant at 0.5 h whereas only a trend is visible 
at 3.5 h. The biological effectiveness of CNO in relation to time is analysed with first placebo 
injection C. saline and then D. CNO. All animals were subjected to 3 h of repeated blood 
sampling for LH between 0.5 and 3.5 h sample collection. Corticosterone concentration did 
not differ with saline treatment either in control or RFRP-hM3Dq female mice. The 
corticosterone concentration in RFRP-hM3Dq mice remained high with CNO treatment in 
comparison to the control mice and did not differ significantly between 0.5 h and 3.5 h 
samples. Data represents mean mean± SEM. Two-way repeated measures ANOVA Holm-
Sidak’s multiple comparisons test.  **P<0.01 
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4.2.2.3 Effect of increased hypothalamic RFRP neuronal activity on LH secretion  
Upregulation in hypothalamic RFRP activity is reported to occur alongside the 
endocrine stress response in both male and female mice (Yang et al., 2017; Yang et al., 
2018). Whether this increase in RFRP neuronal signalling is sufficient to suppress 
GnRH dependent LH secretion was assessed in RFRP-hM3Dq mice. As per Figure 3.5, 
the basal LH secretion profiles for RFRP-hM3Dq and a separate group of control mice 
were developed post saline administration and the effect of hyperactive RFRP 




In control males, the average LH concentration of 0.6±0.39 ng/ml measured after 
saline treatment was not significantly different to the 0.3±0.12 ng/ml observed with 
CNO treatment (t(6)=1.338, P=0.406; Figure 4.17 A) which shows CNO itself has no effect 
on LH secretion. Despite the increased circulating corticosterone concentration with 
CNO treatment in excitatory DREADD expressing RFRP-hM3Dq males, the group 
mean LH concentration (0.4±0.10 ng/ml) was not significantly different from the 
saline treatment (0.5±0.13 ng/ml; t(6)=0.808, P=0.450; Figure 4.17 A).  
 
 Similarly, there was no statistically significant difference observed in LH pulse 
frequency for control mice between saline (1.3±0.19 pulses/h) and CNO (1.1±0.11 
pulses/h) administration (t(6)=0.518, P=0.815; Figure 4.17 B,D,E). Also, there was no 
effect on the LH pulse frequency for the RFRP-hM3Dq mice between saline (1.13±0.29 
pulses/h) and CNO (1.3±0.15 pulses/h) treatment (t(6)=0.601, P=0.815; Figure 4.17 
B,F,G). These results correspond to the RFRP silencing results which, like upregulated 
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RFRP neuronal signalling, also showed no effect on mean LH concentration and pulse 
frequency in males. 
 
The LH pulse amplitude as well between saline and CNO treatment were not 
significantly different for both the control (1.3±0.67 ng/ml saline and 0.5±0.12 ng/m 
CNO; t(6)=0.905, P=0.438) and RFRP-hM3Dq (1.6±0.71 ng/ml saline and 0.8±0.33 
ng/ml CNO; t(6)=1.27, P=0.438) mice (Figure 4.17 C). It should be noted that this 















Figure 4.17 Acute RFRP neuronal hyperactivation does not affect LH secretion in males. A. 
Average LH concentration at basal activity with saline administration (black bars), compared 
with CNO (s.c. 2mg/kg; yellow bars). B. LH pulse frequency under basal condition with saline 
treatment and CNO-induced RFRP activation. C. LH amplitude under saline treatment and 
CNO-induced RFRP activation. Each data point is an average of the LH pulse amplitude for 
an individual animal. Pulses without a preceding nadir were excluded from the analysis. 
Representative LH profiles are as follow: D. Control animal post saline administration E. 
Control post CNO administration F. RFRP-hM3Dq saline administration G. RFRP-hM3Dq 
post CNO administration. Black circles represent pulse peaks. All data presented are 
mean± SEM. Two-way RM ANOVA followed by Holm-Sidak’s multiple comparisons test 
(*P<0.05). Note: limited numbers of animals were available for these experiments.   
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Females 
In light of the rescue effect of silencing RFRP neurons on corticosterone-suppressed 
LH secretion, hyperactivation of RFRP neurons was hypothesised to reduce LH 
secretion in females. There was no significant difference seen in control mice for 
average LH concentration between saline treatment (0.3±0.10 ng/ml) and CNO 
administration (0.4±0.09 ng/ml; t(3)=1.066, P=0.365). In RFRP-hM3Dq mice a trend of 
reduced average circulating LH concentration was observed with CNO treatment, but 
a statistically significant difference was not achieved for the group mean of 0.1±0.07 
ng/ml in comparison to the 0.6±0.15 ng/ml observed under saline treatment 
(t(3)=3.96, P=0.057; Figure 4.18 A).  
 
The pulse frequency was unaffected by the CNO treatment for the control group 
(1.5±0.18 pulses/h saline, 1.7±0.01 pulses/h CNO; t(3)=1.134, P=0.339; Figure 4.18 
B,D,E). However, for the RFRP-hM3Dq mice the basal pulse frequency observed with 
saline treatment (1.7±0.19 pulses/h) was significantly reduced with CNO treatment 
(0.7±0.19 pulse/h; t(3)=7.407; P=0.010; Figure 4.18 B,F,G). Furthermore, this reduction 
in pulse frequency with CNO treatment was significantly (t(6)=6.606, P=0.001) lower 
in RFRP-hM3Dq mice in comparison to the control mice whereas the effect of saline 
(t(6)=0.330, P=0.752) was similar in both control and RFRP-hM3Dq groups (Figure 
4.18 B). 
 
No statistically significant difference in  LH pulse amplitude coinciding with CNO 
treatment was observed for either control (0.6±0.23 ng/ml saline, 0.5±0.02 ng/ml 
CNO; t(3)=0.452, P=0.681) or RFRP-hM3Dq mice (0.9±0.25 ng/ml saline, 0.4±0.07 
ng/ml CNO; t(3)=2.302, P=0.199; Figure 4.18 C). It should be noted that this 
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experiment was limited by small group sizes for both the control and RFRP-hM3Dq 
mice. 










Figure 4.18 Effect of acute RFRP neuronal hyperactivation on LH secretion in female mice. 
A. Average LH concentration at basal activity with saline administration (black bars) 
compared with CNO (2mg/kg; yellow bars) treatment. B. LH pulse frequency under basal 
condition with saline treatment and CNO-induced RFRP activation. C. LH amplitude under 
saline treatment and CNO-induced RFRP activation. Each data point is an average of the LH 
pulse amplitude for an individual animal. Pulses without a preceding nadir were excluded 
from the analysis. Representative LH profiles are as follow: D. Control animal post saline 
administration E. Control post CNO administration F. RFRP-hM3Dq saline administration G. 
RFRP-hM3Dq post CNO administration. Black circles represent pulse peaks. All data 
presented are mean± SEM (control n=3, RFRP-hM4Di n=5). Two-way repeated measures 
ANOVA followed by Holm-Sidak’s multiple comparisons test (*P<0.05, **P<0.01). Note: 





The ability of RFRP neurons to modulate stress and reproductive outcomes remains 
unclear, and their role in linking these two processes is even less well understood. 
Experimental evidence from the Anderson lab has shown central delivery of 
exogenous RFRP-3, a peptide secreted by RFRP neurons, activates stress hormone 
release (Kim et al., 2015) but suppresses reproductive hormones (at least in 
preovulatory females) (Ancel et al., 2017). Therefore, it was hypothesised that 
modulating RFRP neuronal activity in chronic stress conditions may restore 
homeostasis in the HPG axis and thus hormonal determinants of fertility. Until now, 
the animal models that enable experimental manipulation of RFRP neurons had not 
been developed, which limited the scope of research into the effects of endogenous 
RFRP neuronal activity. This thesis shows the characterisation of novel RFRP-Cre-
DREADD expressing mice that allows for selective silencing and hyperactivation of 
RFRP neurons to study their effect on the interaction of the stress and reproductive 
axes.  
 
To characterise the importance of RFRP neuronal activity in glucocorticoid-induced 
inhibition of the reproductive axis, two research questions were posed: firstly, 
whether RFRP neuronal activity is required for inhibition of the reproductive system 
during stress, and secondly, whether activation of RFRP neurons is sufficient to induce 
HPA axis activation and reproductive suppression.  
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By acutely manipulating the activity of RFRP neurons, their temporal control of the 
hormonal output of the HPG axis under stress was observed to be sexually dimorphic 
in nature. Results showed a requirement of RFRP neurons for reproductive 
suppression by corticosterone in female mice while no such requirement was 
observed for males. Hyperactivation of RFRP neurons (in a limited cohort of mice) 
was shown to stimulate corticosterone release in both sexes but only supress pulsatile 
LH release in females.  Further discussed are experimental models for testing the effect 
of endogenous RFRP activity on the glucocorticoid suppression of the pre-ovulatory 
LH surge (which was not able to be successfully carried out in the current study).  
 
5.1 Validation of RFRP-Cre DREADD model  
Compared to the permanent gene knockout manipulations induced during embryonic 
development, acute manipulation of RFRP neuronal activity using DREADDs avoids 
the potential development of compensatory neuronal pathways which may convolute 
the true understanding of the intraneuronal links involved. It further allows for the 
measurement of the real-time neuroendocrine effect. The functionality of excitatory 
DREADD receptors in RFRP-hM3Dq mice and inhibitory DREADD receptors in 
RFRP-hM4Di mice were validated after administering their synthetic agonist CNO. 
DREADD-specific manipulation of the DMH RFRP-neuronal activity was 
characterised by the immunohistochemical co-labelling of RFRP-3 and the tonic 
neuronal activity marker FRA. In contrast to the generally-used activity marker cFos, 
FRA stains all fos-related antigens such as fos-B which has been used previously for 
measurement of the low-level neuronal activity (such as the silencing of RFRP neurons 
in the RFRP-hM4Di mice). Use of FRA has also been previously shown in studies 
characterising allostatic loads of stress or pathologies of the reproductive system 
(Lehman et al., 1996; Szawka et al., 2009; Szawka et al., 2010).  
 98 
 
The overall magnitude of CNO-induced RFRP neuronal activation relative to 
physiological norms is unknown. In the excitatory RFRP-hM3Dq mice, a ~40 % 
increase in RFRP neuron and FRA coexpression was observed, while a ~25 % decrease 
was observed for the inhibitory RFRP-hM4Di mice (Figure 4.11 A-B). It should be 
noted that unlike excitatory DREADD expressing RFRP-hM3Dq mice, the inhibitory 
DREADD expressing RFRP-hM4Di mice were treated with a corticosterone implant 
prior to quantifying the effect of CNO on DREADD receptors. The remarkably high 
activity of RFRP neurons observed in the corticosterone treated control mice for 
Experiment B1 (61.3 % in males and 63.9 % in females; Figure 4.11 A-B) is consistent 
with previous reports in the literature that state ~50 % colocalisation of  Rfrp and Cfos 
in the DMH of mice culled immediately after being exposed to restrain stress (Yang et 
al., 2017). Due to the limitation in the number of RFRP-hM4Di mice, an additional 
experiment testing the efficiency of the inhibitory DREADD response on RFRP 
neurons in basal conditions - without exogenous corticosterone treatment - was not 
possible. 
 
A comparison of DREADD-induced alteration of RFRP neuronal activity to the basal 
activity of these neurons was possible with the addition of the non-experimented ‘no 
implant’ group (Figure 4.8). It is clear that the DREADD inhibitory effect in RFRP-
hM4Di expressing mice with 2 mg/kg s.c. CNO was sufficient to bring RFRP activity 
to basal levels in both male and female mice, despite exogenous corticosterone 
treatment (Figure 4.8). In fact, the DREADD-inhibited levels of FRA coexpression was 
less than that of non-implanted mice with a statistical significance achieved for males. 
While some other neuronal populations such as GnRH neurons have essentially no 
detectable cFos under basal conditions (Quennell et al., 2009), it may be that RFRP 
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neurons always have a detectable level of activity which is also seen in other studies 
using cFos as a marker in these neurons (Kriegsfeld et al., 2006; Kirby et al., 2009; 
Russo et al., 2015). As chronic exposure to high glucocorticoids has been reported to 
enhance RFRP activity (Kirby et al., 2009; Kaewwongse et al., 2011), the low RFRP 
activity (23- 35 %) observed in the chronic corticosterone treated RFRP-hM4Di mice 
strongly validate the effectiveness of the DREADD technology for RFRP neurons  
 
Due to the DMH-restricted localisation of RFRP neurons and hence Cre recombinase, 
mouse lines with Cre-dependent DREADD genes ‘knocked in’ to all cells were used 
for simplicity and to avoid spatial error possible with virus injection delivery of the 
DREADD gene into the DMH. This also means that a small percentage of non-RFRP 
specific Cre expression is expected due to neuroplasticity during development. The 
reprogramming capability of neurons post-embryogenesis enables plasticity at the 
anatomical, electrical and synaptic level (Borrelli et al., 2008). Presently, there is 
minimal evidence for the plasticity of RFRP neurons specifically (Poling et al., 2012), 
but it is a generally accepted neuronal phenomenon that accounts for variability 
resulting from the environment, diet and signals originating from other influences 
during development (Duman et al., 2000).  
 
There is however some evidence for age-dependent variation in the quantity of the 
RFRP neuronal population in both male and female mice where decline in the DMH 
population of these neurons has been observed in the post prepubertal phase (Sethi et 
al., 2010; Poling et al., 2012). Under stress, neuronal apoptosis has been reported in the 
region of the brain such as the hippocampus but the main mechanism for neuronal 
cell death i.e. BAX-dependent apoptosis has shown to not be the cause for declining 
RFRP population during development (Crochemore et al., 2005; Poling et al., 2012). 
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Rather, the authors suggest the likelihood of remodelling RFRP neurons to other 
subsets of neurons; but where these ‘plastic ‘neurons expressed Cre at any stage of 
development, they will continue to express Cre-dependent genes (such as DREADD 
genes) regardless of the adult neuronal phenotype.  
 
A further experiment to quantify coexpression of RFRP-3 peptide with the DREADD-
coupled epitope haemagglutinin (HA) would help identify the percentage of RFRP-
specific DREADD expression. Due to difficulties with fluorescent HA and RFRP-3 
immunostaining these experiments could not be completed for inclusion in this thesis 
but are currently being conducted. Nevertheless, RFRP-specific DREADD expression 
has been quantified previously in our lab for RFRP-hM3Dq mice, using mCitrine as a 
DREADD marker (Chapter 3, Figure 3.2). While 90.2±1.6 % RFRP-3 neurons co-
expressed the hM3Dq tag mCitrine, only 40.0±7.3 % of all mCitrine-labeled cells co-
expressed RFRP-3; this is consistent with the previously-described loss of Rfrp gene 
expression in some cells during pre-pubertal development (Poling et al., 2012). It is 
likely that the same is true for hM4Di mice, and therefore CNO would have been able 
to act on essentially all RFRP neurons, plus some others of unknown phenotype in the 
nearby vicinity that have ceased to express Rfrp.  
 
The Cre-loxP system is a powerful tool for genome manipulation and in this instance 
essential for RFRP-specific DREADD expression. With the increasing use of this 
technology, there have been reports of secondary side effects from Cre recombinase 
insertion. One such example is the Nestin-Cre mice which are used to restrict genetic 
modification to the brain. The expression of the Cre transgene in these mice causes 
impairment in the development of conditioned fear (Giusti et al., 2014). Some studies 
have also associated Cre activity with toxicity and abnormal cell cycle progression 
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(Loonstra et al., 2001; Janbandhu et al., 2014). In such instance, studies conducted 
without Cre expressing animals in the control group introduce the possibility of an 
experimental confound in their findings. To account for the potential adverse effect of 
this gene, mice with genotypes Cre-positive, DREADD-negative and Cre-negative, 
DREADD-positive were used in the controls of this study. These mice did not have a 
difference in the body weight or in length of the oestrous cycle compared to each other 
or to the RFRP-hM4Di or RFRP-hM3Dq mice in the absence of CNO treatment. 
 
The analysis of RFRP-3 and FRA colocalisation after CNO treatment and the induction 
of excitatory and inhibitory effects in RFRP-hM3Dq and RFRP-hM4Di mice 
respectively, is the key finding validating functionality of RFRP-specific DREADD 
expression. These results clearly show that the transgenic model used in this thesis 
successfully led to manipulation of RFRP neuronal activity to study their role in stress-
induced infertility. 
 
5.2 Emulating a physiological stress response 
Stress models in this study were created by imitating the enhanced physiological 
response of the HPA axis with elevation of corticosterone concentration in the 
circulation. This was executed via exogenous corticosterone delivery. Two methods 
were tested: a series of s.c. injections on the day of LH sampling, or a s.c. corticosterone 
implant placed at least 4 days prior to sampling. The latter proved to be the most 
efficient method of elevating corticosterone in the treatment group, as results were not 
confounded by the stress of repeated corticosterone injections on the day of sampling 
and hence an adequate non-stressed control group was able to be established.  
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5.2.1 Subcutaneous corticosterone injection 
The acute injection delivery method was initially chosen as it allowed for the 
progression of the oestrous cycle in female mice. Hence, it provided the possibility of 
measuring the effect of elevated corticosterone on the naturally occurring pre-
ovulatory LH surge, by simply emulating a relatively short-term endocrine stress 
response on the day of proestrus. The injection delivery method for exogenous 
corticosterone has been an effective model on other stress related studies, and where 
a singular dose is administered, a rather small effect on baseline corticosterone for 
vehicle injected controls is reported (Breen et al., 2012; Kim et al., 2019). In my study 
however, in order to consistently sustain stress-like corticosterone levels for much of 
the day of preovulatory LH surge experiment, a repeated injection (1 mg/kg every 3 
h) approach was required. However, the repeated injections presented a confounding 
effect of delivery method, since both the saline and corticosterone treated groups had 
significantly higher corticosterone concentrations (> 100 ng/ml) compared to the non-
injected mice (Figure 4.3A). Ultimately, no significant difference in the mean 
corticosterone concentration was observed between the corticosterone-injected and 
saline-injected mice (Figure 4.3). The substantial magnitude of endogenous 
corticosterone response triggered by repeated vehicle injection appeared to be of 
sufficient magnitude to suppress the pre-ovulatory LH surge in the saline treated 
control mice (Figure 4.2). While the seemingly high stress responses to vehicle 
injections were surprising and are not easily explained, overall the results present the 
need for a higher exogenous corticosterone dose (> 3 injections of 1mg/kg) that can 




5.2.2 Subcutaneous corticosterone implant 
The use of in-house made s.c.  corticosterone implants (~100 mg) that were developed 
from methodology established by Luo et al. (2016), provided the required higher 
stress-like elevated glucocorticoid levels without the need for repeated injections. As 
seen in Figure 4.9, the s.c. placement of these implants exhibited a typical HPA axis 
response to chronic stress, which lasts over multiple days in persistent stress-induced 
infertility. The first use of these implants in control mice delivered promising results 
of significantly higher plasma corticosterone compared to mice without a 
corticosterone implant (Figure 4.6). However, the delivery of corticosterone from 
these implants was inconsistent as a considerable amount of variability (day 3 
measurement ranging from 40-550 ng/ml; n=7) was observed in the data set (Figure 
4.6). Additionally, the Luo et al. (2016) paper reported a higher plasma corticosterone 
concentration of ~700 ng/ml on day 15 of implantation that consisted of a lower dose 
(42.5 mg) corticosterone implant. These differences may be due to uneven coating and 
of differing surface area.  
 
In the second preparation of these s.c. implants, subtle modifications were made to 
smoothen the surface area by intermittently layering the silicone pellet and moulding 
by hand (Figure 3.5 B). These implants showed reduced variability in corticosterone 
concentrations among mice. Blood samples were collected on the days following the 
implant placement to characterise the pattern of corticosterone release into the 
systemic circulation (Figure 4.9). The 5-day duration tested for these implants showed 
a spike in plasma corticosterone concentration on day 2 and then a more consistent 
elevation in plasma corticosterone only between day 4-5 (Figure 4.9A). To my 
knowledge, this is the first report on the daily pattern of corticosterone release from a 
s.c.  implant in an in vivo model. Unlike the day 2 concentration, the day 4-5 plasma 
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corticosterone concentration of 400-500 ng/ml is closer to the physiological 
glucocorticoid response reported in the literature for chronically stressed mice (Breen 
et al., 2012; García-Eguren et al., 2019). The role of RFRP neurons in stress-induced 
reproductive suppression for Experiment B1 was characterised on implant day 4-5, 
within the physiologically relevant stress-like elevation in circulating glucocorticoid 
levels.  
 
Long term exposure to stress-like glucocorticoid levels, as seen from corticosterone 
implants, is known to adversely affect metabolic homeostasis and disrupt the oestrous 
cycle in female mice (Breen et al., 2012; García-Eguren et al., 2019). The Luo et al. (2016) 
paper also reported a significant increase in oestrous cycle length during the 15-day 
corticosterone treatment. Due to the short 5-day duration of my experiment, 
measuring the effect of corticosterone on the oestrous cycle length was not feasible.  
However, the percentage of time spent in each stage of the oestrous cycle was 
calculated, and similarly to the Luo et al. (2016) report, a significant reduction in the 
occurrence of proestrus and oestrus was observed (Figure 4.11).  Therefore, these 
implants were realistically limited to use in an artificially-occurring LH surge 
paradigm (rather than naturally occurring preovulatory surges on the day of 
proestrus), and tonic pulsatile LH secretion that occurs outside of proestrus.  
 
In terms of the allostatic load of stress on metabolism, a significant decrease in body 
weight observed within 3-day use of corticosterone in oestradiol treated OVX female 
mice as seen in Figure 4.4, is substantiated by similar experiments in OVX female rats. 
The study by Rabin et al. (1990) reported a decrease in body weight in 3-day oestradiol 
and corticosteroid (dexamethasone) treated OVX rats in comparison to only oestradiol 
treated OVX rats. Contrastingly, studies with intact mice have reported a positive 
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association of corticosterone treatment with body weight gain. García-Eguren et al. 
(2019) showed mice that had chronic administration of 100 µg/ml corticosterone in 
drinking water for 4 days showed an increase in body weight in comparison to the 
vehicle treated mice. This bears similarities with the findings of Experiment B1, which 
had sustained chronic elevation of circulating corticosterone for a minimum of 4 days 
and exhibited a significant increase in body weight for all groups with glucocorticoid 
treatment compared to pre-treatment.  
 
5.3 Reproductive effect of manipulating hypothalamic RFRP neuronal activity 
This study identifies a novel sexually dimorphic role of RFRP neurons in modulating 
glucocorticoid-specific induced suppression of LH pulses. Previous studies of RFRP 
neurons, focusing on chronic stress and reproductive dysfunction, have mainly used 
paradigms of psychosocial stress through external stimulators such as restraint and 
isolation, and rarely included males and a comparison of sex effects (Kirby et al., 2009; 
Yang et al., 2017; Yang et al., 2018). This thesis is the first study to examine the 
modulatory role of RFRP neurons on the reproductive effects of chronically elevated 
glucocorticoid secretion, in male and female mice. Due to the difficulties encountered 
modelling a typical proestrus-like LH surge, the results discussed here are on the 
effect of pulsatile LH secretion. 
 
Females 
Acute RFRP silencing was sufficient in females to overcome the glucocorticoid-
induced reduction of gonadotropin secretion. During chronic high glucocorticoid 
treatment all parameters of LH secretion - mean concentration, pulse frequency and 
amplitude – were rescued to the pre-corticosterone levels in RFRP-hM4Di female mice 
(Figure 4.12). In Figure 4.12, the reasons for a lower basal LH concentration (pre-
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corticosterone treatment) observed in RFRP-hM4Di female mice compared to control 
mice are unknown. Nevertheless, this was controlled for, by each animal acting as its 
own control for glucocorticoid-induced LH suppression. More importantly, the LH 
pulse frequency with corticosterone treatment was significantly lower for control mice 
in comparison to the RFRP-hM4Di mice, despite both groups exhibiting a similar 
corticosterone concentration (Figure 4.9). This clearly shows that RFRP activity is 
crucial for inducing the suppressive effect of glucocorticoids on LH secretion. 
Supporting this temporal role of RFRP neurons in female reproductivity activity, is 
the previously mentioned in vivo study by Geraghty et al. (2015), which examined 
chronically stressed naturally cycling rats, and observed reproductive dysfunction 
such as fewer pregnancies, reduced copulatory events and embryo reabsorption, 
which were alleviated with knockdown of RFRP neurons using an Rfrp short hairpin 
RNA lentivirus.  
 
Further supporting the influence of RFRP neurons on LH secretion is the novel 
demonstration that the hyperactivation of RFRP neurons is associated with increased 
endogenous corticosterone secretion, and with concurrent suppression of LH pulse 
frequency and secretion. These experiments for assessing the reproductive effects of 
hyperactive RFRP neurons in the absence of exogenous corticosterone treatment were 
ceased early due to the COVID-19 lockdown, and therefore could not be examined in 
a larger sample. Nonetheless, findings from the limited sample size correlate with the 
prior observation of exogenous RFRP-3, which when centrally administered, resulted 
in increased glucocorticoid secretion, and therefore adds to the positive feedback role 
of RFRP neurons on the HPA axis (Kim et al., 2015). LH pulse frequency suppression 
induced by hyperactive RFRP neurons has not been studied before. From these 
observations it can be concluded that RFRP neuronal excitation alone is sufficient to 
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induce the endocrine stress response as well as diminish the HPG axis hormonal 
secretion in female mice. Collectively from the Experiment B1 and B2 data, it can be 
summarised that glucocorticoids upregulate the inhibitory action of RFRP neurons on 
reproductive hormone secretion in female mice. This effect is presumably further 
exacerbated by RFRP neurons also stimulating the HPA axis endocrine stress response 
to sustain glucocorticoid-induced reproductive dysfunction. 
 
Males 
Neither the inhibition nor hyperactivation of RFRP neuronal activity showed evidence 
for a significant role of these neurons in stress-induced reproductive hormone 
suppression in male mice. The contrasting absence of a rescue effect on glucocorticoid-
suppressed LH secretion by silencing RFRP neurons (Figure 4.12) was complemented 
by the result of uninterrupted LH secretion in the presence of hyperactive RFRP 
neurons (Figure 4.17). Interestingly though, hyperactivity in the RFRP neuronal 
population resulted in an acute but significant elevation in glucocorticoid secretion 
(~900ng/ml) that was similar to the concentration observed in female RFRP-hM3Dq 
mice. However, unlike females, this relatively high glucocorticoid concentration was 
not sufficient to suppress LH secretion or pulse frequency in male mice. This 
contradicts the Experiment B1 male data which demonstrated significant suppression 
of LH pulses and mean concentration with chronic s.c. corticosterone implant 
treatment. It may be that long-term glucocorticoid exposure as seen with implant 
treatment is capable of suppressing the reproductive axis in male mice. In contrast, 
acutely elevated glucocorticoid levels, as seen with the hyperactivation of RFRP 
neurons, is not sufficient to suppress HPG axis hormonal secretion. Such was also 
observed in a human study in which circulating LH concentration in men, measured 
every 10 mins for 6 h, remained unchanged before and during acute exposure to 
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glucocorticoid treatment (Veldhuis et al., 1992). This is further supported by the 
findings that males in general are reported to be less susceptible to stress than females 
in both humans and mice, and therefore may not carry as great an allostatic load of 
HPA axis activation (Breslau et al., 1997; Brougham et al., 2009; Juster et al., 2010). In 
an alternate scenario, if the hyperactivity in the RFRP neuronal population had been 
long-lasting due to extended CNO treatment, the subsequent suppression of LH with 
sustained high glucocorticoid levels would still remain a possibility 
 
A comparable study by Ancel et al. (2017) reported contradictory findings where acute 
i.c.v. RFRP-3 administration in mice during the course of tail tip blood sampling 
reduced plasma LH concentration in intact males and not in naturally cycling 
dioestrus females. This study, however, also reported a suppressive effect of 
exogenous RFRP-3 on the LH surge in both intact and OVX female mice. All findings 
were reported by measurement of LH samples collected every 15 mins for a period of 
1.25 h. While this sampling method is sufficient for measuring the sustained high 
concentration of a surge, it was of insufficient intensity for assessment of the pulsatile 
secretion pattern of LH in both males and dioestrus females. In this thesis, samples 
were collected with shorter time intervals, i.e. every 6 mins for an extended period of 
3 h; this not only permits pulse assessment but also provides a better sample set for 
mean LH concentration measurement. An additional effort was made to maintain the 
sensitivity of the LH assay by decreasing the dilution volume to 54 µl (i.e. 14-fold) 
compared to 150 µl (31-fold) used in Ancel et al. (2017). Other reports that looked at 
pulsatile LH secretion with frequent sampling intervals such as in my study, also 
show the suppressive effect of exogenous RFRP-3 (1 µg) on LH pulse frequency and 
mean plasma LH concentration in OVX female rats (Murakami et al., 2008). However, 
another similar study with OVX oestradiol-treated female rats reported that higher 
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doses of 2.5 and 25 µg central RFRP-3 administration had no effect on episodic LH 
release (Anderson et al., 2009). It has also been reported that a dose of 500 ng but not 
100 ng i.c.v. RFRP-3 suppresses all facets of male sexual behaviour (Johnson et al., 
2007). In the latter study, a single blood sample was collected for LH measurement by 
culling the animals 20 mins after i.c.v. RFRP administration and the authors reported 
a significant reduction in plasma LH compared to vehicle treatment. 
 
Literature on the reproductive role of RFRP greatly varies, with its effect mainly tested 
by exogenous RFRP-3 administration. There are inconsistencies in hormone sample 
collection protocols, gonadal status as well as the dose and route of RFRP-3 
administration. In my study, measurements have been taken to test the effect of 
endogenous RFRP activity to accurately unravel the physiological role of RFRP 
neurons in real-time during stressed and unstressed conditions. A particular 
advantage is that the s.c. administration of CNO prior to LH sampling is far less 
invasive and stressful than i.c.v. injections during frequent sampling. Although the 
concentrations of RFRP-3 achieved still remain unknown, they are at least within the 
physiological range that the RFRP neurons are capable of achieving. The same cannot 
be said for central injections of exogenous RFRP-3. 
 
5.4 Sexually dimorphic role of RFRP neurons 
The reasons for the more evident inhibitory role of RFRP neurons in females 
compared to males are currently unknown. It may be that RFRP neurons are 
influenced differently by the developmentally programmed sex-specific neuronal 
circuit, or perhaps by sex steroids. Previous experiments in our lab using RFRP-
hM3Dq mice showed that the chronic hyperactivity of these neurons delayed puberty 
onset in males but not in females (Sawyer, 2017). This suggests that the magnitude of 
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the reproductive effect of RFRP neurons is greater in males during adolescence, and 
as my study shows, more prominent in females during adulthood (at least in a stress-
like setting). In a small clinical trial consisting of five male and five female participants 
reported a 50 µg/kg/h intravenous (i.v.) RFRP-3 delivery over a 3 h period 
suppressed LH secretion in females but not males (George et al., 2017). Collectively, 
these findings suggest that although RFRP neurons are stimulated with stress in both 
sexes, their subsequent response on the reproductive system is more elaborate in 
females and not as much in males.  
 
There is sparse evidence for the influence of sex steroids on RFRP neurons and it is 
mainly oriented around oestrogenic effects. It is noteworthy that oestradiol is able to 
influence both RFRP and CRH neurons directly via alpha and possibly also beta 
oestrogen receptor isoforms (Handa et al., 2011; Poling et al., 2012). As androgen 
receptors (ARs), in contrast to ERα, are reported to be virtually undetectable in the 
RFRP neurons of both female and male mice (Poling et al., 2012), it may be that RFRP 
neurons are specifically responsive to oestrogens among sex steroids. With 
testosterone being the predominant sex steroid in males, and RFRP neurons 
essentially lacking the cellular machinery to be responsive to androgens, they 
therefore may not play as important a role in male fertility. It is likely that RFRP 
neurons in the basal conditions, with their low level activity mentioned earlier, send 
inhibitory signals to the GnRH and kisspeptin neurons to aid in controlled pulsatile 
gonadotropin secretion that is vital for gonadal function in females. The extension of 
RFRP fibres to GnRH and the kisspeptin neurons along with the presence of RFRP-3 
receptor, GPR147, on the membrane of these neurons, supports the RFRP-mediated 
modulation of subsequent gonadotropin secretion (Kriegsfeld et al., 2006; Rizwan et 
al., 2012; Poling et al., 2013). However, in females for ovulation to occur, rising 
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follicular phase oestradiol levels acting via ERα would suppress RFRP activity to 
‘gate’ the LH surge. Both Molnar et al. (2011) and Poling et al. (2012) show that the 
otherwise sustained ~30-45 % basal level of RFRP cFos coexpression in OVX female 
mice is reduced to below 20 % in the presence of pre-ovulation like oestradiol 
treatment. A similar experiment where both male and female mice were treated with 
implants containing the active form of testosterone, the dihydrotestosterone implants, 
no effect on RFRP activity, cell numbers or cellular expression of Rfrp was reported 
(Poling et al., 2012). 
 
Hence it is possible that in females, the phenomenal switch between pulsatile LH 
secretion and a surge which is regulated by oestradiol negative and positive feedback, 
respectively, might also be aided by the upstream regulatory role of RFRP neurons. 
Therefore, it may be that the homeostatic balance of the HPG axis, aided by the minor 
contribution of basal inhibitory activity of RFRP neurons, is exploited in the presence 
of glucocorticoids to suppress gonadotropin secretion and ovulation – and thus 
conserve energy in times of duress (Figure 5.1). In contrast to females, males have a 
simpler HPG axis construct with negative feedback at all times on GnRH secretion 
and on the LH secreting pituitary gland, which perhaps makes the upstream 
inhibitory RFRP function redundant. The lesser importance of RFRP neurons in 
inhibiting the GnRH neurosecretion in males may explain why these neurons are not 




Figure 5.1 A proposed oestrogen and glucocorticoid synchronised regulation of RFRP 
activity. Glucocorticoids may stimulate RFRP neurons via the glucocorticoid receptors (GRs)  
expressed by these neurons (Kirby et al., 2009), and this increase in RFRP activity is observed 
in the immunohistochemical data of corticosterone treated control mice in Experiment B1. 
Under basal conditions, stimulation from the low levels of circulating glucocorticoids may be 
counteracted by the inhibitory effect of oestrogens via the ERα receptors expressed by the 
RFRP neurons (Molnar et al., 2011). However, during stress, the endocrine stress response acts 
to inhibit the HPG axis and therefore lower circulating oestrogen levels (Herrera and Mather, 
2015). The absence of negative oestrogenic regulation combined with the abundant 
glucocorticoid secretion under stress may increase RFRP activity and enhance their inhibitory 
reproductive effect in females. 
 
 
5.5 Future directions 
5.5.1 Refining the pre-ovulatory LH surge mouse model 
While some studies have shown a negative regulation of the exogenous RFRP-3 on 
the pre-ovulatory LH surge, whether RFRP neurons themselves are required to 
enhance the suppressive effect on the pre-ovulatory LH surge during chronic stress, 
remains to be tested. In this thesis, two different surge models in emulating the 
endocrine stress response were assessed in order to test the role of endogenous RFRP 
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activity. Due to scarcity of RFRP-DREADD expressing mice, these assessments were 
done on the intact proestrus female control mice and oestradiol treated OVX control 
mice to measure naturally occurring and artificially-induced LH surges, respectively. 
Although ultimately unsuccessful here, both models exhibit potential with a refined 
methodology. 
 
The first attempt at measuring the LH surges in naturally cycling mice was promising 
until repeated injection delivery of corticosterone and saline was introduced 
throughout the afternoon leading up to the surge. This proved to be stressful enough 
to prevent reliable surge occurrence even in mice well habituated to this type of 
handling. A less stressful method of drug delivery would be mixing corticosterone 
into drinking water, which has been shown to significantly increase circulating 
corticosterone levels (Bittar et al., 2019). In forthcoming experiments,  to test whether 
RFRP neurons are required for glucocorticoid-induced suppression of the pre-
ovulatory LH surge, a mixture of both corticosterone and CNO could be administered 
in drinking water to RFRP-hM4Di mice. This would simultaneously silence RFRP 
neurons as well as emulate the endocrine stress response throughout the day of 
proestrus. Likewise, to test if the hyperactivity of the RFRP neuronal population seen 
during chronic stress is sufficient in suppressing the LH surge, circulating LH levels in 
RFRP-hM3Dq mice could be measured in the absence of any external stressor and with 
sole administration of CNO in drinking water on the day of proestrus. Together, these 
experiments would show whether RFRP neurons are an essential component of the 
hypothalamic-neuronal circuitry mediating glucocorticoid-induced pre-ovulatory LH 
surge suppression.  
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For inducing an artificial LH surge in OVX mice, a strategy that better mimics the 
follicular phase leadup to the surge involves a low dose negative feedback oestradiol 
implant (1 µg per 20 g body weight for 6 days). Then to produce the elevated 
proestrus-like positive feedback seen in intact naturally cycling mice, oestradiol 
benzoate (1 ug in 100 µL) is injected 32 h prior to the LH surge (Czieselsky et al., 2016); 
this is referred to as the oestradiol rise model. It is the most consistent method used in 
the literature and has also been used in previous publications from the Anderson lab 
(Quennell et al., 2009; Quennell et al., 2011; Zuure et al., 2013; McEwen et al., 2016; 
Ancel et al., 2017). Unfortunately, difficulties have been encountered to get this model 
working in the last 3 years; hence an alternate approach based on a protocol from 
Christian et al. (2005) and Luo et al. (2016) was used in my experimental model. Based 
on these protocols, the use of 0.65 µg oestradiol implants were expected to produce an 
LH surge of ~5 ng/ml on day 3 of the implantation. Due to variability in baseline 
concentrations before the surge, a 10-fold increase was used to define a surge rather 
than a fixed threshold value. The mean LH concentration exhibited in my study on 
day 3 of implantation was ~1 ng/ml and a diurnal pattern was undetectable. 
Additionally, these values were too low to see suppressive effects with corticosterone 
treatment, thus preventing me from being able to characterise the effect of RFRP in 




Figure 5.2 The oestradiol treatment induced LH surge in OVX mice is a lower amplitude 
than the preovulatory proestrus surge. Here shown are results from a study by Silveira et al. 
(2017) which measured serum LH concentration within 30 mins of lights out in day 3 OVX 
mice treated with a 0.65 µg s.c. oestradiol implant (OVX-E; grey circles, n=15) and proestrus 
mice (black circles, n=9). Note the log scale; each symbol represents 1 mouse; mean±SEM 
values indicated by the horizontal and vertical lines. Data analysed with Student t-test 
(*P<0.001). These results coincide with the findings of Experiment A in this thesis with 
proestrus intact female mice exhibiting > 10 ng/ml LH surge whereas all concentrations with 
oestradiol treatment in OVX mice were < 1 ng/ml (see Figure 4.1 and 4.7). Considering these 
results, the naturally occurring surge approach allows an adequate range of LH concentration 




Furthermore, the unexpected occurrence of the highest LH concentration in the no 
implant OVX mice raises a question of whether 0.65 µg oestradiol implants used in 
my study were acting as negative feedback regulators of the HPG axis (Figure 4.7; 
Appendix B). Consistent with the findings of Experiment A (Figure 4.7), a study by 
Czieselsky et al. (2016) also shows that the LH concentration range of ~2-6 ng/ml 
observed in steroid untreated OVX mice is significantly reduced in the presence of a 
low dose oestradiol implant (Czieselsky et al., 2016). Therefore, when reconducting 
this experiment, an oestradiol implant with a higher dose (> 0.65 µg) should be used. 
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As oestradiol treatment is known to affect uterine weight, this should be measured as 
a proxy for oestradiol concentration (since commercial ELISAs lack the sensitivity to 
detect physiological levels of mouse oestradiol) to identify the effectiveness of 
oestradiol delivery from these implants. These parameters have not been reported in 
Christian et al. (2005), Luo et al. (2016) or in my study, as this model and any 
experiments involving it were made redundant due to time constraints. However, 
such measurements, as performed to characterise the efficacy of the corticosterone 
implants in Experiment B2, are vital for characterising drug dose delivery and their 
effectiveness in vivo. In hindsight, it may also have been worthwhile to collect an extra 
sample after lights out, since LH surges induced in the oestradiol implanted mice have 
been shown to persist until 30 mins after lights turn off (Czieselsky et al., 2016). The 
effect of a 14 h light:10 h dark cycle as used by Christian et al. (2005) vs the 12 h:12 h 
cycle used in my study should also be assessed. 
 
Lastly, extra care must be taken in terms of environmental factors when reassessing 
both naturally occurring and artificially induced LH surges as they have been shown 
to impact fertility (Tolson and Chappell, 2012). Rooms with stacked IVC cages can at 
times limit the amount of light received and thus potentially dampen the 12 h light 
transitions. Since surges, unlike pulses, are extremely circadian dependent, the 
potential impact these external environmental factors, that govern the circadian 
rhythm of mice, should not be underestimated. Conducting these experiments in a 
room with open top cages and ensuring sufficient light is reached to each cage may be 
beneficial. Additionally, housing males in the same room with open top cages may be 
of benefit as male pheromones have shown to improve reproductive cyclicity in 
female mice (Byers et al., 2012). 
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5.5.2 Mapping neuronal pathways whereby psychosocial stress leads to 
suppression of reproduction 
This thesis, via in vivo manipulation of RFRP neurons, successfully shows the 
effectiveness of these neurons in regulating the hormonal response of the HPG and 
HPA axes. While the effect of RFRP neurons to enhance glucocorticoid secretion is 
shown for both sexes, the disruption of LH secretion is only clearly seen in females. 
This discrepancy in the effectiveness of RFRP neurons in regulating the reproductive 
axis under stress should be further investigated by measuring the effect of 
electrochemical and electrophysiological properties of these neurons on GnRH, 
kisspeptin and CRH neurons, and in the presence of sex steroids.  
 
It would be important to study whether RFRP neurons are influenced by oestradiol to 
aid in GnRH pulse and surge generation. Microdialysis is a widely used technique in 
neuroscience through which a stereotaxically implanted polycarbonated probe in the 
brain collects dialysate from the interstitial fluid, driven slowly through a tubular 
semipermeable membrane, and allows measurement of extracellular 
neurotransmitters, peptides, and hormones in the freely moving animal (Chefer et al., 
2009). Inserting a probe into the DMH would allow quantification of RFRP 
neurosecretion in the interstitial fluid in mice treated with surge-like high oestradiol 
levels or with low levels of oestradiol observed during GnRH and LH pulse secretion. 
Previously, a similar experiment has been performed in rhesus monkeys using 
microdialysis to show involvement of positive feedback of i.v. transfused surge-like 
oestradiol levels in generating the GnRH surge (Manabe et al., 1993). Considerable 
progress has since been made to perform this technique in mouse models. Further, 
replicating this experiment with testosterone treatment will also aid in understanding 
whether this steroid is capable of regulating RFRP neurons. 
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This thesis along with others, demonstrates that glucocorticoid treatment increases 
RFRP activity. Currently evidence for the direct activation of RFRP neurons by 
glucocorticoid signalling mainly stems from the presence of GR and GRE in these 
neurons, and the absence of upregulated RFRP neuronal activity by stress in 
adrenalectomised mice. Using fibre photometry with calcium influx as the indicator, 
RFRP neuronal activity should be documented in vivo in the presence and absence of 
chronic subcutaneous glucocorticoid implant treatment. A similar experiment has 
been done on CRH neurons where the adeno-associated virus expression of 
fluorescent calcium indicator GCaMP6s in the CRH-Cre mice and the optical 
recordings visualised via two-photon microscopy has enabled understanding of the 
glucocorticoid feedback regulation of the CRH neurons (Kim et al., 2019). Replicating 
this GCaMP6s expression and fibre photometry recording in the RFRP-Cre mice 
would be the first set of data to assess and show direct glucocorticoid induced 
upregulation of RFRP neuronal activity in real-time in vivo recordings. In the absence 
of an external stress stimulus, tonic activity is measured by the low irregular 
GCaMP6s transients which would enhance if glucocorticoid exposure induces RFRP 
depolarisation. These fibre photometry recordings have been shown to measure spike 
rate within milliseconds (Bucher and Wightman, 2015), and therefore would allow 
measurement of activity of single neurons and help gain an insight into how 
hypothalamic RFRP neurons are regulated by stress.  
 
Lastly, to dissect the true inhibitory effect of RFRP neuronal signalling on the 
reproductive axis, it should be studied in the absence of stimulation on the CRH 
neurons. This thesis showed that hyperactivation of RFRP neurons in RFRP-hM3Dq 
mice increased glucocorticoid secretion in both male and female mice. Since central 
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administration of RFRP-3 has been shown to depolarise CRH neurons, and these 
neurons directly inhibit the reproductive axis, it can be postulated that the activated 
RFRP neurons partly sustain their inhibitory reproductive effect in chronic stress by 
activating CRH neurons. While it is proposed in the literature (Chapter 2) that RFRP 
neurons are able to centrally exert their inhibitory effect on the reproductive axis via 
their GPR147 receptor expressed by the GnRH and kisspeptin neurons, studies to date 
have not yet measured the direct effects on GnRH and kisspeptin neurosecretion in 
the absence of CRH activity. Adding a sex comparison could help to confirm if there 
is a lower effectiveness of inhibitory RFRP signalling in males. This possibility is 








Figure 5.3 The proposed RFRP regulated hypothalamic neuronal network of the HPG and 
HPA axis under stress. Stress results in the stimulation of CRH neurons in both sexes, which  
through a cascade of events causes a release of glucocorticoids from the adrenal gland. These 
neurons either directly or by their downstream effector, glucocorticoids, inhibit the GnRH 
stimulator, kisspeptin, to disrupt LH secretion required for gonadal function and therefore 
cease gonadal steroid secretion in both sexes (Takumi et al., 2012). Simultaneously 
glucocorticoids act to increase RFRP activity which was shown by the s.c. corticosterone 
implant treatment in Experiment B1 for both control male and female mice .Only in females, 
this increase in RFRP activity may possibly inhibit GnRH neurons and the ARC kisspeptin 
stimulation to disrupt pulsatile LH secretion. Once activated, RFRP neurons may stimulate 
CRH neurons to further enhance glucocorticoid secretion; thereby maintaining a positive 
feedback loop to sustain their inhibitory effect on the reproductive axis and cause persistent 
infertility. In males, since no effect on LH secretion was observed with the manipulation of 
RFRP activity, this opposes the efficiency of the inhibitory role of these neurons on GnRH and 
the ARC kisspeptin. However, upregulation of RFRP activity observed with chronic stress, 
may increase glucocorticoid secretion as seen with the hyperactivation of RFRP neurons in 
Experiment B2. Therefore, RFRP neurons may still act to sustain the reproductive axis-
suppressing CRH activity in chronic stress if not by directly acting on the hypothalamic GnRH 
neuronal network. (solid line = pronounced effect during stress, dashed line = diminishing 
effect with endocrine stress response)  
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5.6 Conclusion 
The neuronal pathways whereby psychosocial stress leads to suppression of 
reproduction, up until now, remain poorly understood. Collectively, data from this 
thesis demonstrates that RFRP neurons are an essential component of the 
hypothalamic neurocircuitry mediating stress and reproductive hormone secretion. 
These results build on previous findings that RFRP neurons are activated in response 
to stressful situations. The real-time effect of DREADD dependent RFRP neuronal 
signalling manipulation in vivo shows for the first time that RFRP neurons are able to 
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A   Recipes 
 
Agarose Gel 
To make a ‘big gel’ for ≤40 wells  
• Combine 1.6 g of agarose with 80ml TAE buffer and bring to the boil (in 
microwave) 
• Cool to ~60 ˚C and add 5 µl ethidium bromide and mix 
• Pour into corresponding tray with combs inserted and allow to set for 20 
mins. 
 
Citrate Buffer (0.1 M, pH 5.0) 
To make 1L in ddH2O 
• Combine 10.3 g of citric acid monohydrate and 18.16 g of sodium phosphate 
(Na2HPO4.2H2O). 
• Make up to 1 L with distilled water 
• Adjust pH to 5.0 
 
Cryoprotectant 
To make 1L 
• Combine 300 g sucrose, 10 g PVP, 300 ml ethylene glycol dissolved in 500 ml 
0.1M PO4 buffer 
• Make up to 1 L with distilled water 
 
Diaminobenzidine (DAB, 0.05%) 
To make 20mL 
• Add 1 tablet DAB and 1 tablet urea to 20 ml of distilled water and dissolve 
• Use immediately for IHC staining 
 
For nickel-enhanced staining 
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• Add 160 mg Ni(NH4)2SO4 with 1 tablet DAB and 1 tablet urea to 20 ml of 
distilled water and dissolve 
 
EDTA (0.5 M, pH 8.0) 
To make 250 ml 
• Add 46.525 g EDTA to 150mL milli-Q water 
• Adjust pH with NaOH to 8.0 
• Make up the 250 ml with milli-Q water 
 
Lysis buffer (pH 8.5) 
To make 1 L 
• Add 12.11 g Tris base, 1.86 g EDTA, 2 g SDS and 11.68 g NaCl to 500 ml of 
distilled water and dissolve 
• Make up to 1L with distilled water 
• Adjust pH to 8.5 
 
Paraformaldehyde 4% (pH 7.3) 
To make 500 ml 
• Measure 250 ml of 0.2M PB and set aside 
• Measure 250 ml of ddH2O and heat to ~55 ˚C 
• Weigh out 20 g PFA and add to heated ddH2O 
• Add 5-6 drops of 10 M NaOH 
• Leave to dissolve with a stirring rod for ~10 mins, do not heat above 60˚C 
• Once dissolved, cool solution and filter before adding to 0.2 M PB 
• Adjust pH to 7.3 
 
Phosphate Buffer (PB, pH 7.3) 
To make 100 ml 0.2M PB 
• Combine 32 ml dibasic and 8ml monobasic solutions (i.e. 4:1 ratio) 
• Add 60 ml milli-Q water 
• To make up 1 L of 0.5M dibasic (disodium hydrogen phosphate) weigh out 
89g disodium phosphate (Na2HPO4.2H2O; molecular weight of 177.99) and 
make up to 1 L with milli‑Q water 
 147 
• To make up 500 ml of 0.5 M monobasic (sodium dihydrogen phosphate) 
weigh out 39 g of sodium dihydrogen phosphate (NaH2PO4.2H2O; molecular 
weight 156.01) and make up to 500 ml with milli‑Q water 
 
Phosphate Buffered Saline (PBS, pH 7.3, 0.1 M) 
To make 2 L of 10 x PBS 
• Add 163.4 g NaCl, 27.6 g NaH2PO4.2H2O and 35.6 g of Na2HPO4.2H2O to 2 L 
of distilled water 
• Adjust pH to 7.3 
 
Phosphate Buffered Saline‑Tween20 (PBS-T) 
• 1x PBS-Tween20 (0.1 M PBS, 0.05 % Tween20, pH 7.4) 
• Add 250 µl Tween20 for 500 ml 1xPBS 
• Readjust pH to 7.4 as Tween20 will affect pH. Store at RT. 
 
Sucrose 30% 
To make 100 ml 
• Dissolve 30 g of sucrose in 100 ml of 1xPBS 
 
Tris-Acetate EDTA Buffer (TAE) (pH 7.2) 
To make 1 L of 10 x TAE buffer 
• Add 48.4 g of Tris base, 11.4mL of glacial acetic acid and 3.7 g of EDTA to  
800 ml of distilled water 
• Adjust pH to 7.2 
• Make up to 1 L with distilled water 
 
Tris-Borate EDTA Buffer (TBE) (pH 8.3) 
To make 1L of 10x TBE 
• Add 108 g Tris base, 55 g boric acid and 9.3 g EDTA to 1 L of distilled water 
 
 
Tris-Buffered Saline (TBS, pH 7.8, 0.05 M) 
To make 2 L of 10 x TBS 
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• Add 12.12 g of Trizma HCl, 2.78 g Trizma base, 17.4 g of NaCl to 2 L of 
distilled water 
• Adjust pH to 7.8 
 
Tris-EDTA Buffer (TE) (pH 8) 
To make 1 L 
• Add 1.211g Tris base and 0.372 g of EDTA to 800 ml distilled water 
• Adjust pH to 8 
• Make up to 1 L with distilled water 
 
TBS-TritonX (TBS-TX) 




B   Genotyping results: PCR agarose gel for DREADD and Cre expression 
 
 
i. Cre positive and DREADD negative control mouse 
ii. Cre positive and DREADD hM4Di heterozygous mouse 
iii. Cre positive and DREADD hM4Di homozygous mouse 
iv. Cre negative and DREADD positive control mouse 
 
The DNA ladder in the left lane indicates 100 base pair steps. In the hM4Di gel, the 
440 base pair bands indicate the hM4Di mutant allele and the 300 base pair bands 
indicate the wild type allele. In the RFRP-Cre gel, the 400 base pair bands indicate the 













C   CNO dose preliminary data  
 
 
Relationship between CNO administration and corticosterone secretion in RFRP-
hM3Dq male mice. Subcutaneous injection of 1 mg/kg CNO was not sufficient to 
induce a significant increase in endogenous RFRP activity. A higher dose of 2 mg/kg 














To quantify endogenous RFRP activity the following 3 neuronal activity markers were 
tested: i. pCreb (1:160; Cell Signalling Inc #9191), ii. cFos (1:1000; Calbiochem, #AB5) 
and iii. FRA (1:2000; Santa Cruz Biotechnology K-25; RRID: AB_2231996). All three 
sections belong to the same mouse from the corticosterone-treated control group. 
Immunochemical staining was carried out as per section 3.4.7. Brain sections were first 
stained for RFRP-3 prior to labelling the activity markers. RFRP neuronal activity was 
best visible with FRA staining. Left images were taken with 100x magnification, right 
images with 400x magnification. (black = nuclear staining, brown = cytoplasmic 
staining) 
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E   Vaginal cytology readings before and after ovariectomy  
 
i. No implant ii. Oestradiol implant 
iii.          Oestradiol 
+ 
   corticosterone implants 
   
 
For mice in Experiment A, difference in time spent in cycle stage were assessed in 12 
days before OVX and 3 days after OVX and steroid treatment. P, E, M and D represent 
proestrous, oestrous, metoestrus and dieostrus-like smears respectively. All mice 
exhibited a regular 4-5 day oestrous cycle prior to OVX.  No implant OVX mice (i) 
maintained a dieosteros like smear throughout the course of the experiment. 
Occurrence of the oestrous like smear persisted in OVX mice with oestradiol implant 
(ii) and mice with both oestradiol and corticosterone implants (iii). Summary data is 




F   LH profile for individual animals of each OVX group 
 
i. No implant ii. Oestradiol implant 
iii.          Oestradiol 
+ 
   corticosterone implants 
   
   
 
Oestradiol implants used to artificially induce LH surge in Experiment Aii caused a 
reduction in the circulating LH concentration levels in OVX mice. Blood samples 
collected for basal LH measurements at 1100, 1400h, 1700 and surge measurement in 
the hour before lights out (1800, 1830, 1900h) showed the highest level of LH 
concentration in OVX mice without oestradiol treatment i.e. the no implant group (i). 
The OVX mice with oestradiol implant (ii) and mice with both oestradiol and 
corticosterone implants (iii) exhibited less than 3 ng/ml LH concentration on the third 
day of implantation. Summary data is in Figure 4.7 A. 
 
 
